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 Section 1 describes a systematic literature review examining psychological correlates 
of perceived social support in multiple sclerosis.  Five subject databases (CINAHL; 
EMBASE; PsycINFO; PubMed; Web of Science) were searched using a single search string 
(correlates OR factors AND “social support” and “multiple sclerosis”).  Of the 21 articles 
reviewed, 20 reported statistically significant relationships.  Most studies (n = 11) correlated 
perceived social support with depression or mental health aspects of quality of life and all 
found the higher the social support, the lower depression and higher positive mental health.  
Studies using regression identified that greater social support was a significant predictor of 
lower anxiety, anger, depression, loneliness and better mental aspects of health-related 
quality of life, postpartum emotional distress and self-esteem.  The results provide evidence 
for significant relationships between social support and various psychological variables. 
 Section 2 describes a research study which aimed to identify whether a lack of social 
support and increased levels of perceived stigma predicted psychological distress for 
individuals with motor neurone disease (MND).  Correlational and hierarchical regression 
analyses were conducted.  Significant correlations were identified between social support, felt 
and enacted stigma and measures of psychological distress.  Regression analyses revealed 
that enacted stigma was not an independent predictor in any of the models and social support 
did not remain a significant independent predictor for stress when stigma entered the model.  
Moreover, felt stigma was a more powerful significant independent predictor in all the 
models.  It may be important to consider social support and stigma when aiming to improve 
psychological distress for individuals with MND. 
 Section 3 describes a critical and reflective appraisal of aspects of the whole 
thesis.  This includes an overview of the main findings, discusses recruitment issues, the 





conceptual framework of disability employed to guide the terminology usage, and makes 
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Purpose: Social support has been identified as a significant correlate and predictor of 
variables relating to psychological distress and well-being in neurological conditions.  This 
review aimed to discover if perceived social support was a significant correlate and predictor 
of psychological variables for individuals with multiple sclerosis (MS).  The definition of 
psychological variables adopted for this review related to psychological distress, well-being 
and concepts such as depression, self-esteem, mental aspects of health-related quality of life 
and other mental health outcomes.  Methods: A systematic literature review was conducted 
using five electronic databases and a single search string.  Articles were systematically 
screened and those which met the inclusion criteria were included in the review (n = 21).  
Results:  Of the 21 articles reviewed, 20 reported statistically significant relationships.  The 
correlations with the largest effect size were found between social support and depression, 
hope and mental composite of quality of life, whereby higher levels of social support 
correlated with lower depression and increased hope and better mental-health related quality 
of life.  The variable with the largest number of studies and significant results was 
depression, followed by mental aspects of health-related quality of life.  Regression results 
identified that greater social support was also a significant predictor of lower anxiety, anger, 
depression, loneliness, and better mental aspects of health-related quality of life, postpartum 
emotional distress and self-esteem.  Conclusions: The results provide evidence for 
significant relationships between social support and various psychological variables.  
However, more robust research is required to improve the quality of these findings. 
Keywords: Social support, depression, quality of life, correlates, multiple sclerosis  
 
 






Social support is a complex concept, with varying definitions (Berkman, Glass, 
Brissette & Seeman, 2000).  For example, it has been described in terms of a social network 
structure, often measured quantitatively (Hirsch, 1980; Hutchinson, 1999), which is 
comprised of a set of significantly present others through which social support is gained.  A 
sociological perspective provided by Durkheim (1951), proposed that membership of social 
groups can create a sense of belonging and provide meaningfulness to an individual’s life, 
and that lack of socialisation can lead to hopelessness and despair.  This suggests that 
individuals’ level of integration within their social network can directly affect their 
psychological well-being.  However, it has also been argued that being embedded in social 
networks can also affect both positive and negative outcomes.  For example, Burg and 
Seeman (1994) reported that a larger social network size does not always provide positive 
health outcomes for individuals with physical health conditions, as extensive networks can 
produce costs as well as benefits.  Furthermore, Chak (1996) criticised using social network 
as a conceptualisation for social support because this assumes that all social interactions are 
helpful.   Alternatively, satisfaction with social support, rather than the size of the social 
network may be important and, was emphasised theoretically in Lazarus and Folkman’s 
transactional stress model (1984), which proposed that the individual’s evaluation of the 
support as being adequate was vital to avoid distress.   
A further conceptualisation is that of perceived social support.  This concept was first 
theorised by Sarason and colleagues (Sarason, Sarason & Shearin, 1986; Sarason, Pierce & 
Sarason 1990; Sarason et al., 1991) and is considered one of the most well researched 
concepts of social support (Chronister, Johnson & Berven, 2006).  This conceptualisation 
suggests that how social support is perceived by the individual is most important.  While 
similar to satisfaction with social support, it differs in that perceived social support does not 





focus entirely on the levels of satisfaction with that support, rather, it refers to the 
individual’s perception of support (i.e. perceived levels/ amount of support received, 
perceived satisfaction with support received, perceived sources of support etc.)  Perceived 
social support is useful in that it is specific and has been widely used in both research in this 
field and as a construct within most definitions and measures of social support (Chronister et 
al. 2006; Chiu, Motl & Ditchman, 2016).  As such, this understanding of social support will 
be used within this quantitative systematic literature review.   
The way in which social support is related to health has been theorised by Heaney and 
Israel (2008) who hypothesise that social support is the starting point of a causal flow to 
health outcomes.  They state that, in actuality, some of these relationships could be reciprocal 
as health status can influence the extent to which an individual can maintain and recruit social 
support.  In this model, social support can influence health behaviours through a direct 
pathway by impacting physical, mental and social health or through indirect pathways of 
individual coping resources or organisational and community resources.  Moreover, this 
model will be used as a theoretical framework to guide the results of this review and to 
illustrate this conceptualisation of the relationship between social support and psychological 
factors.   
Perceived social support has been useful in research investigating psychological 
distress and well-being across a wide range of physical health conditions such as women at 
risk of hereditary breast cancer (den Heijer et al., 2010); Parkinson’s disease (Saeedian et al., 
2014; Garlovsky, Overton & Simpson, 2016); individuals accessing cardiac care (León-
Pérez, Wallston, Goggins, Poppendeck & Kripalani, 2016; Sirri, Magelli & Grandi, 2011); 
fibromyalgia (van Koulil, van Lankveld, Kraaimaat, van Riel & Evers, 2010), rheumatoid 
arthritis (Evers, Kraaimaat, Geenen & Bijlsma, 1997); motor neurone disease (Matuz, 
Birbaumer, Hautzinger & Kübler, 2010; Matuz, Birbaumer, Hautzinger & Kübler, 2015) and 





epilepsy (Gandy, Sharpe & Perry, 2011).  One condition where social support is particularly 
important is multiple sclerosis (MS), a progressive autoimmune condition.  Research has 
identified that as an individual’s level of impairment increases (some of which can be due to 
the limitations and barriers which society impose; Simpson & Thomas, 2014), more support 
may be required.  As people with MS tend to be of working age, support needs may change 
over time.   
 The effects of MS vary between individuals and can be difficult to predict, as the 
effects and severity can vary over time.  MS can affect multiple sites across the central 
nervous system including the cerebral hemispheres, optic nerve, spinal cord and brainstem.  
There are five subtypes of MS, which include relapsing remitting, secondary progressive, 
primary progressive, progressive relapsing and benign; with relapsing remitting being the 
most common (Malik, Donnelly & Barnett, 2014).  
 Psychological difficulties and their management are important aspects of holistic care 
for individuals with a diagnosis of MS and extensive research has been conducted in this 
field.  Many studies have been conducted in relation to depression (McIvor, Riklan & 
Reznikoff, 1984; Mohr, Classen & Barrera, 2004; Patten, Metz & Reimer, 2000) and it has 
been reported that this is the most common psychological difficulty (Minden & Schiffer, 
1993).  Other psychological difficulties have also been explored, such as agitation, irritability, 
apathy, euphoria, disinhibition, hallucinations and delusions (Diaz-Olavarrieta, Cummings, 
Velazquez & Garcia de al Cadena, 1999); anxiety (Diaz-Olavarrieta et al., 1999; Korostil & 
Feinstein, 2007); mood, fatigue, self-efficacy (Motl, McAuley, Snook & Gilottoni, 2009); 
self-esteem (Foote, Piazza, Holcombe, Paul & Daffin, 1990; O’Brien, 1993); and quality of 
life (Motl et al., 2009).  As the above studies outline, psychological difficulties can be 
common in individuals with a diagnosis of MS and while a number of factors contribute to 





this, the contribution of social support is an important determinant to review, especially given 
its potential to be changed.   
A quantitative approach was taken for this review as the vast majority of research 
conducted in this area utilises quantitative methods, which mainly assess statistical 
relationships between predictive and outcome measures.  Although qualitative research has 
been conducted on social support, this mainly focuses on the relationship between social 
support and physical aspects of the condition such as exercise and fatigue (Carroll, Chalder, 
Hemingway, Heyman & Moss-Morris, 2016; Christensen, Brincks, Schnieber & Sørensen, 
2015; Christensen , Brincks, Schnieber & Sørensen, 2016; Chiu, Bezyak, Griffith & Motl, 
2016; Dlugonski, Joyce & Motl, 2012).   
Previous reviews have been conducted which have focused on depression and MS 
(Arnett, Barwick & Beeney, 2008) and psychosocial correlates of adjustment in MS 
(Dennison, Ross-Morris & Chalder, 2009).  There is some overlap between these reviews and 
the current review, as perceived social support was included as a psychosocial factor within 
the Dennison et al. (2009) review and as a correlate of depression in the Arnett et al. (2007) 
review.  However, these reviews were conducted at least 10 years ago, and social support was 
not the focus of these reviews, rather one of several components.  Furthermore, the way in 
which the Dennison et al. (2009) review was theorised differs from the current review, as 
they were seeking predictors of adjustment outcomes, whereas the current review was 
seeking research investigating social support and its relationship with other psychological 
variables.  Therefore, the current review aims expand on these, by identifying more recent 
research and by assessing the specific concept of perceived social support.   
 This systematic literature review therefore aims to provide an overview on the 
research to date that has investigated the relationship between perceived social support and 





psychological outcomes relating to well-being and distress for individuals with a diagnosis of 
MS.  Adopting a broad definition of psychological correlates has advantages and 
disadvantages; one advantage of such a definition is the alignment with previous literature on 
adjustment.  Moreover, this definition provides an original, comprehensive review of the 
impact of perceived social support on emotional and behavioural psychological factors for 
people with MS.  However, by adopting this definition, other variables which relate to 
cognitive or neuropsychological functioning, or which could be conceptualised from either a 
physical or psychological perspective, such as pain and fatigue, were not included.  
Furthermore, by including a range of disparate factors which have been found to be 
correlated with social support necessitates the need to consider the results within an overall 
conceptual framework.   
Despite a wealth of literature being available on the influence of social support on 
such outcomes, no systematic review has been completed in this area previously.  
Consequently, this quantitative systematic literature review aims to enhance the evidence 
base by assessing the robustness of relationships between psychological variables and 
perceived social support, so that appropriate interventions can be identified, drawing upon 
theories of social support.  This includes studies which used social support as a predictor 
(independent variable) or an outcome (dependent variable) as both of these theoretical 
perspectives capture relationships of interest.   
Method 
Search Strategy 
 The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; 
Moher, Liberati, Tetzlaff & Altman, 2009) checklist was used to guide the structure of this 
review (see Appendix 1-A).  Consultation with a subject-specific librarian took place prior to 





searches being undertaken to maximise the efficiency of the searches.  Five individual subject 
databases were searched electronically using the single free text search string: correlates OR 
factors AND “social support” AND “multiple sclerosis”.  Each subject database was searched 
individually using the above single search string.  The databases used for this search were 
CINAHL (Cumulative Index to Nursing & Allied Health), EMBASE (Excerpta Medica), 
PsycINFO, PubMed and Web of Science.  These databases were selected as they were the 
most relevant ones for health, neurology, psychology and medicine at the time the searches 
were conducted.   
 The search string used was selected as it encompassed all the aspects of the search in 
a succinct way, yielding the maximum relevant results.  No date exclusion criteria were set 
for the searches and these were conducted on 5th February 2019, so articles published up to 
this date were included.  The inclusion criteria were that the article had to investigate 
psychological correlates of perceived social support with individuals with a diagnosis of MS 
(including self-report of diagnosis).  Also, both the measures of social support and the 
psychological variables had to be shown to be statistically valid and reliable either by the 
study using the measure or by previous research.  Psychological correlates were defined as: 
“potentially modifiable factors relating to the individual’s attitudes, thoughts, feelings, and 
behaviours that would be relevant and possible to address in a psychological intervention” 
(Dennison et al., 2009, p.142).  Articles were excluded if they were: not published in English, 
qualitative articles, review articles, conference papers, commentary articles, presentation 
abstracts or articles which investigated family members/ caregivers of an individual with a 
diagnosis of MS.  Articles were also excluded if they used a different construct of social 
support.  Thus, articles were excluded which did not investigate perceived social support; did 
not include an emotional support construct; looked at marital/ partner support rather than a 
broader concept of social support; the construct of social support related specifically to 





function or work.  Finally, if a quality of life measure was used then this had to provide 
separate scores for physical and mental components of quality of life, as only the mental 
components were included in the review.  These criteria were used to ensure that only studies 
investigating psychological correlates, using a concept of perceived social support, with 
individuals with a diagnosis of MS were included in the review.  To be as inclusive as 
possible and to gain a broader view of the topic, there was no restrictions on age of 
participants or location of the research.   
 The initial search was conducted using the search string and databases outlined above, 
the duplicates were removed, and title screening was conducted to exclude any irrelevant 
articles.  Screening was continued using the article abstracts and any articles that did not meet 
the inclusion criteria or met the exclusion criteria were removed.  The same process was 
followed for remaining articles using the full-text.  Following the different stages of 
screening, 19 articles remained from the initial searches, and a further two articles were 
identified through snowballing from these articles, resulting in a total of 21 articles included 
in the systematic review (see Figure 1 for a flow diagram outlining this process). 
 The type of studies included in this review reported correlational and regression 
analyses that measured relationships between perceived social support and psychological 
variables (as defined above) in individuals with a diagnosis of MS.  Studies were included if 
they used social support as a predictor (independent variable) or an outcome (dependent 
variable) as both theoretical perspectives capture relationships of interest.  For the purpose of 
this review, pain and fatigue were not considered psychological correlates, as these were 
reported in terms of physical health and physical activity within the studies (Motl, McAuley, 
Snook & Gilottoni, 2009; Osborne et al., 2006; Osborne, Jensen, Ehde, Hanley & Kraft, 
2007) and were therefore categorised as a physical correlate and excluded from the review.  





The method by which these variables were collected included self-report and clinician 
administered measures.   
--------------------------------------- 




 Quality assessments were conducted to assess the quality of each article, and 
to provide a framework for the results to be viewed, the quality assessment was not used to 
exclude articles.  An amended version of the NICE (National Institute for Health and Care 
Excellence) quality appraisal checklist – quantitative studies reporting correlations and 
associations (2012; see Appendix 1-B) was used for this purpose.   This tool was specifically 
developed for assessing correlational studies and is based on the appraisal step of the 
‘Graphical appraisal tool for epidemiological studies (GATE)’ developed by Jackson et al. 
(2006).  This tool allows the reviewer to rate the study’s internal and external validity by 
viewing the key aspects of the study design (participants’ characteristics, definition of 
independent variables, outcomes assessed and methods of analyses).  The tool includes five 
sections, with section one relating to external validity and sections two to four relating to 
internal validity with the fifth section providing a summary of scoring for the external and 
internal validity.  There are 17 questions spread over the first four sections and each is rated 
on a scale, with five possible responses (see Appendix 1-C for scoring descriptions).  For the 
purposes of this review, only 16 of the questions were used, with question 2.5 being omitted, 
as this question related to the applicability of the setting to a UK sample, which is not 
relevant for this review.  For this review, one main reviewer assessed each study, and 25% of 





the studies (n = 6) were reviewed again by a second reviewer (psychology graduate, 
undertaking a doctoral clinical psychology programme).  The reviewers then cross-checked 
the ratings and any discrepancies were discussed, and a rating mutually agreed, to enhance 
their reliability.  The results of the quality assessment were used to enhance the findings of 
the review, by providing a framework to view the quality of the individual study’s findings.  
The quality assessment results were taken into consideration when drawing conclusions about 
the strength of the findings relating to specific variables, to either consolidate or dispute the 
conclusions drawn.  See Table 1 for the outcome of the quality assessment ratings.  
 
--------------------------------------- 
Insert Table 1 here please 
    --------------------------------------- 
 
Results 
 Of the 744 identified articles, duplicates were removed leaving 435 articles; these 
were screened by title and irrelevant articles were removed (n = 233).  This left 202 articles 
which were then screened by abstract to see if they met the inclusion or exclusion criteria.  
Records were excluded if they did not meet the inclusion criteria (n = 149).  The remaining 
53 articles were assessed for eligibility using the full-text and articles that did not meet the 
inclusion criteria or met the exclusion criteria were excluded (n = 32; see Appendix 1-D for 
list of articles and reasons for exclusion).  This resulted in a final total of 21 studies which 
were included in the overall review (see Figure 1).   
Study Characteristics 
 The main study characteristics of the 21 reviewed studies can be found in Table 2.  
The date range for the studies was from 1984 until 2018, with the majority being conducted 





in the past 11 years (n = 11).  Thirteen studies (62%) were conducted in the USA, with the 
remainder being completed in Australia (McCabe, McKern & McDonald, 2004), Egypt 
(Effat, Azzam, Shalash, Elkatan & Elrassas, 2016), France (Gay, Vrignaud, Garitte & 
Meunier, 2010), Israel (Schwartz & Frohner, 2005), Lebanon (Farran, Ammar & Darwish, 
2016), Poland (Jaracz et al., 2010), Portugal (Costa, Sá & Calheiros, 2012) and Saudi Arabia 
(Hyarat, Al-Gamal & Rama, 2018). 
Despite the intended inclusion of studies which used social support as either a 
predictor (independent variable) or an outcome (dependent variable), all the studies identified 
in this review theorised social support as a predictor (independent variable) and the 
psychological variables as outcomes.  Most studies (n = 19) were cross-sectional single time 
point studies, apart from Gulick and Kim (2004) and Koelmel, Hughes, Alschuler & Ehde 
(2017) which both included a longitudinal element to their research design.    
The type of participants also varied across the studies, with all articles including 
individuals with a diagnosis of MS, which was assessed through self-report, physician 
confirmed, laboratory confirmed or confirmed through medical records.  Some studies were 
aimed at specific MS populations, such as veterans with a diagnosis of MS (Bambara, Turner, 
Williams & Haselkorn, 2011), women with a diagnosis of MS (Beal & Stuifbergen, 2007; 
Harrison & Stuifbergen, 2002), individuals with a diagnosis of relapsing-remitting MS 
specifically (Dlugonski & Motl, 2012; Effat et al. 2016; Suh, Weikert, Dlugonski, Sandroff & 
Motl, 2012), mothers with a diagnosis of MS (Gulick & Kim, 2004), individuals with a 
diagnosis of MS who were hospitalised on a neurological ward (Jaracz et al., 2010) and non-
hospitalised individuals with a diagnosis of spinal cord form of MS (McIvor et al., 1984).  Of 
the four studies that included comparison groups (Bamer, Cetin, Johnson, Gibbons & Ehde, 
2008; Effat et al., 2016; Jaracz et al., 2010; McCabe et al., 2004), one used an ‘eastern’ and 
‘western’ sample from the USA (Bamer et al., 2008) and both samples included individuals 





with a diagnosis of MS and were used to compare locations (urban and rural).  The other 
three studies included an MS group and a control group with ‘healthy’ individuals for 
comparison (Effat et al., 2016; Jaracz et al., 2010; McCabe et al., 2004).  Hence, a variety of 
general and specific MS populations are included in the review, with the majority (57%) 
being conducted with a general MS population, which included the varying types.   
Of the studies for which a response rate was applicable (n = 19), 26% (n = 5) did not 
report a response rate (Costa et al., 2012; Effat et al., 2016; Gay et al., 2010; Jaracz et al., 
2010; McIvor et al., 1984).  Of the studies that did report a response rate the lowest response 
rate for a MS sample was Bamer et al., (2008) with a response rate of 39.3% in the ‘eastern 
sample’ group.  The highest response rate for an MS sample was Hyarat et al. (2018) with a 
100% response rate.  There was only one study (Bambara et al., 2010) who reported the 
characteristics of non-responders to identify any potential responder bias.   
The number of MS participants across all the studies totalled 4,628.  This total was 
calculated following removal of the ‘healthy’ control group numbers (n = 429) and removal 
of duplicate samples (see Appendix 1-E for further information).    
Demographic data for the participants with a diagnosis of MS were reported for 99% 
of the participants (n = 4,599).  The demographic data for one study (Schwartz & Frohner, 
2005) were not included in these totals as the authors provided demographic data for 82 
participants but only included 69 participants in the analysis.  Of the demographic data of the 
4,599 participants reported, 73% were female (n = 3,339) which is in line with the prevalence 
rates of individuals with a diagnosis of MS (around 2-3 times more common in females than 
males; Raffel, Wakerley & Nicolas, 2016).  For the ‘healthy’ control groups (n = 429), 65% 
were female (n = 279).  For the participants with a diagnosis of MS and for whom the age 
range was reported (n = 13), the ages ranged from 18 to 95 years and for the ‘healthy’ control 
groups of which the age range was reported (n = 2), the ages ranged from 18 to 65 years.  





Eleven of the studies reported ethnicity of the MS participants, and this information can be 
viewed in Table 2.  There were no data on ethnicity for any of the comparison group studies.   
Most of the studies (n = 15) had sample sizes of 100 or above, with four studies 
having a sample size lower than 75 (Dlugonski & Motl, 2012; Farran et al., 2016; Foote et al., 
1990; Schwartz & Frohner, 2005).  One study conducted by Effat et al. (2016) had a total of 
90 participants but only 60 of these were individuals with a diagnosis of MS, with the other 
30 participants in a comparison group.  The study with the largest sample size was Bamer et 
al. (2008) which had a sample size of 1,171 participants.   
 
--------------------------------------- 




 The most commonly used social support measure was the Medical Outcomes Study 
Modified Social Support Scale (MSSS; Sherbourne & Stewart, 1991) which was used in six 
of the studies.  All the other measures of social support were used less frequently and can be 
seen in Table 2.  The most frequently measured form of psychological distress within the 
studies was depression (n = 10) and the most widely used measures of depression were the 
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001), the Center for 
Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) and the Beck Depression 
Inventory (BDI; Beck, Ward, Mendelson, Mock & Erbaugh, 1961), all of which were used 
twice.  The measures used in each study, including their reliability and validity, were 
reviewed during the quality assessment process.  All the studies scored a + for this area, 
indicating that the studies may not have addressed all potential sources of bias for this aspect 





of study design, as all the measures used were subjective self-report measures.  Although this 
is controversial by criticising self-report, this is how the quality assessment tool rated self-
report measures.  Moreover, the reliability and validity of the measures was either mentioned 
in the articles or were checked by the author.    
 McCabe et al. (2004) used four subscales (depression, tension, fatigue and confusion) 
of the POMS-SF (the Profile of Moods States – Short Form; Shacham, 1983) to measure 
adjustment.  They defined adjustment as depression, anger, anxiety, fatigue and confusion 
and they used the tension subscale to measure anger and anxiety.  For the purposes of this 
review the confusion and fatigue components were not required, therefore only the scores for 
depression and tension components were used.  Hence, these scores were not conceptualised 
as adjustment, rather the individual components of depression, anger and anxiety. 
Statistical Analyses 
 The statistical analyses employed across the studies were considered appropriate for 
the study designs; five of the studies conducted correlational analyses only, a further four 
studies conducted different types of regression analyses and the remaining 12 studies 
combined both correlational and regression analyses.  Two of the 12 studies which combined 
correlational and regression analyses (McIvor et al., 1984; O’Brien, 1993) did not report the 
variance contributed by social support to the model separately and therefore the results of 
these could not be reported.  
Findings 
Indirect pathway: individual coping resources. 
The following results depict an indirect effect of social support on outcomes of 
psychological distress using individual coping resources, based on the theoretical framework 
of Heaney and Israel (2008).  This suggests that social support can enhance an individual’s 
ability to problem solve and cope with health-related stressors which then influences their 





physical, mental and social health.  Coping has been defined as a form of behaviour which 
aims to manage internal and environmental demands that exhaust an individual’s resources 
(Lazarus & Folkman, 1984).  Coping can be separated into two forms; problem-focused and 
emotion-focused.  Problem-focused coping relates to efforts aimed to manage the source of 
stress directly by altering the situation, whereas emotion-focused coping aims to manage the 
source of stress by dealing with the emotional reaction (O’Brien, 1993).   
Coping. 
One study investigated the relationship between social support and problem-focused 
coping behaviour (O’Brien, 1993).  No statistically significant correlation was identified 
between social support and problem-focused coping. 
Direct pathway. 
The following results depict a direct effect of social support on outcomes of 
psychological distress based on the theoretical framework of Heaney and Israel (2008).  This 
suggests that social support is directly related to physical, mental and social health which 
then influences health behaviours.    
Anger and anxiety. 
One study (McCabe et al., 2004) investigated the relationship between social support, 
anger and anxiety, measured using the tension component of the POMS-SF.  More social 
support was a significant predictor of less anger and anxiety for female participants, but not 
males.   
Anxiety. 
 Koelmel et al., 2017 studied the relationship between social support and anxiety 
using a longitudinal design.  Statistically significant, although small, negative correlations 
were found between social support and anxiety for at least one of the social support 
components at each of the time points, with higher levels of social support associated with 





lower levels of anxiety.  They also identified that greater social support was moderately 
predictive of less anxiety at subsequent time points.     
Depression. 
Ten studies assessed the relationship between social support and depression, of these, 
seven conducted correlational analysis, which all found statistically significant negative 
correlations, where greater social support was associated with less depression.  These 
significant results ranged from small effect sizes, above .10, (Bambara et al., 2011), medium 
effect sizes, above .30 (Gay et al., 2010; Harrison & Stuifbergen, 2002; Suh et al., 2012) to 
large effect sizes, above .50 (Hyarat et al., 2018; McIvor et al., 1984).  Koelmel et al. (2017) 
conducted a longitudinal study and found statistically significant, although small, negative 
correlations for a least one of the social support components at each of the time points, with 
greater social support being associated with less depression.   
These significant relationships mainly remained in the regressions, greater social 
support was a significant predictor of less depression over and above demographic and 
clinical variables (Bambara et al., 2011; Bamer et al., 2008; Chwastiak et al., 2002).  McCabe 
(2004) also identified more social support as a significant predictor of less depression for 
female participants.  However, the same relationship was not identified for male participants.  
Harrison and Stuifbergen (2002) also identified more social support as a significant predictor 
for less depression in mothers with MS, over and above the other variable included in the 
model, concern for children.  Suh et al. (2012) also found that more social support was a 
significant predictor of less depression when included with physical activity and social 
support remained significant even when mobility disability and perceived stress entered the 
model.  Koelmel et al.’s, (2017) longitudinal study identified that greater social support was 
moderately predictive of less depression at subsequent time points.     
Hope. 





One study (Foote et al., 1990) found a statistically significant positive correlation, 
with a large effect size, between social support and hope, with higher levels of social support 
associated with higher levels of hope. 
Loneliness. 
One study (Beal & Stuifbergen, 2007) assessed the relationship between social 
support and loneliness; a correlational analysis showed higher levels of social support were 
associated with lower levels of loneliness, with medium effect size.  This relationship 
remained in the regression, as more social support was found to be a significant predictor of 
less loneliness, over and above the variables of functional limitation, self-rated health status, 
social response of illness and marriage. 
Mental aspects of health-related quality of life. 
Five studies investigated the relationship between social support and mental health 
aspects of quality of life.  Of these, four conducted correlational analyses with three of these 
finding significant positive correlations for all aspects of social support components (Farran 
et al., 2016; Schwartz & Frohner, 2005; Jaracz et al., 2010), with greater social support being 
associated with better mental aspects of quality of life.  Of these, two reported large effect 
sizes (Farran et al., 2016; Schwartz & Frohner, 2005) and Jaracz et al. (2010) reported a mix 
of small and medium effect sizes for the different components of social support.  Effat et al. 
(2016) reported mixed results.  They found statistically significant positive correlations 
between social support and the vitality and mental health components of the MSQLI, with 
medium effect sizes.  Higher levels of social support were associated with better mental-
health related quality of life.  Conversely, no significant correlations were identified between 
social support and the social functioning and role emotion components, in contrast to the 
results found by Schwartz & Frohner (2005) who used the same measure of mental health 
aspects of quality of life.   





Results were also mixed at regression, as Costa et al. (2012) found that only the 
psychological support component of social support was a significant predictor of all aspects 
of the mental components of health-related quality of life when demographic, clinical and 
disability variables were included in the model.  The material support component was not 
identified as a significant predictor for any of the mental components of health-related quality 
of life.  Jaracz et al. (2010) found that social support was not identified as a significant 
predictor when included with demographic, clinical and depression variables in the model.  
However, when depression was removed from the model, social support became a significant 
predictor, over and above demographic and clinical variables. Schwartz and Frohner (2005) 
found a similar result, as they only included demographic and clinical factors alongside social 
support and found social support to be a significant predictor of mental health related quality 
of life beyond all other variables. 
Mental health status. 
One study (Koelmel et al., 2017) investigated the relationship between social support 
and general mental health status longitudinally.  Statistically significant positive correlations, 
ranging from small to medium effect sizes, were found between social support and general 
mental health status for at least one of the social support components at each time point.  
Greater social support was associated with better general mental health status.  These 
significant findings remained at regression as they identified that greater social support was 
moderately predictive of better general mental health status at subsequent time points.     
Postpartum emotional distress. 
One study (Gulick & Kim, 2004) assessed the relationship between social support and 
postpartum emotional distress, using longitudinal correlational and regression analyses.  They 
found that all, but one, deficit components of social support (difference between support 
received and importance of this support) showed statistically significant positive correlations 





with emotional distress at each of the time points, with greater support deficit associated with 
more emotional distress.  The only exception was for the instrumental support deficit 
component at month one, as a statistically significant negative correlation was identified, 
suggesting that the greater the instrumental support deficit, the less emotional distress.  
Interestingly, this relationship reversed at three months and six months as a statistically 
significant positive correlation was identified.  The effect sizes of these correlations ranged 
from small to large.  Regressions were conducted at the three time points and only the 
emotional support deficit component entered the model.  Greater emotional support deficit 
was identified as a significant predictor of increased postpartum emotional distress at all three 
timepoints.   
Psychosocial adjustment. 
One study (Sullivan et al., 2004) assessed the relationship between social support and 
psychological adjustment, which they conceptualised as healthcare orientation, vocational 
environment, domestic environment, sexual relationships, social environment and 
psychological distress (measured using a single scale: Psychosocial Adjustment to Illness 
Scale; PAIS; Derogatis, 1986).  They found a statistically significant, although small, 
negative correlation between social support and psychological adjustment, with higher levels 
of social support associated with better adjustment.  They also found that social support was 
not a statistically significant predictor of adjustment in the regression. 
Self-esteem. 
Two studies (Dlugonski & Motl, 2012; Foote et al., 1990) investigated the 
relationship between social support and self-esteem, using both correlational and regression 
analyses.  Statistically significant positive correlations were found between social support and 
self-esteem, with medium effect sizes, whereby higher social support was associated with 
higher self-esteem.  This finding remained at regression as increased social support was 





found to be a statistically significant predictor of increased self-esteem, over and above 
physical activity.   
Quality Assessment 
Only one of the 21 articles reviewed scored the maximum score for both external and 
internal validity (Schwartz & Frohner, 2005).  There was only one study which received a 
single negative rating for either of the validity components (Foote et al., 1990) which was for 
internal validity.  All the other studies scored at least one positive rating or the highest rating 
for either or both components.  This suggests that the overall quality of the papers can be 
considered as moderate to good results.   
Only one study (O’Brien, 1993) failed to find a statistically significant correlation, 
which was between social support and coping.  This study had not reported a power 
calculation but had a sample size of 101 participants, sufficient to demonstrate a medium 
effect.  It scored a + rating on the quality assessment due to the sample size and the 
representation of the sample was similar to that of the prevalence of MS (gender ratio and 
ethnicity).  One aspect in which there was a lack of information was the question regarding 
the completion of the outcome measurements, as only six studies reported information 
regarding missing data and completion rates of the outcome measures.  All the studies which 
reported this scored positively on this question (Bambara et al., 2011; Bamer et al., 2008; 
Dlugonski & Motl, 2012; Foote et al., 1990; Koelmel et al., 2017; Sullivan et al., 2004).  As 
the other fifteen studies did not report this information, it is not possible to determine whether 
there were any missing data and if so, how this had been managed.   
All the studies used a cross-sectional design, with only two studies also including a 
longitudinal element (Gulick & Kim, 2004; Koelmel et al., 2017).  A potential limitation to 
using this design is the lack of evidence surrounding causality; cross-sectional study designs 
do not allow for a distinction between cause and effect (Mann, 2003).   





The most positively reported items on the assessment was the section relating to 
analyses, with seven studies (Bambara et al., 2011; Bamer et al., 2008; Chwastiak et al., 
2002; Costa et al., 2012; Gulick & Kim, 2004; Jaracz et al., 2010; Koelmel et al., 2017) 
scoring the maximum rating of ++ for each question in the section.   
Discussion 
Each paper, except one (O’Brien, 1993), included in this systematic review reported 
at least one statistically significant finding in relation to perceived social support and 
psychological variables in individuals with a diagnosis of MS.  The results found were 
consistent with the direct pathway of the theoretical model proposed by Heaney and Israel 
(2008) as positive correlations were found between social support and these variables (hope, 
mental aspects of health-related quality of life, mental health status, postpartum emotional 
well-being and self-esteem), whereby higher levels of social support were associated with 
higher levels of these variables.  Social support was also found to negatively correlate with 
anxiety, anger, depression, loneliness, psychological adjustment, where greater social support 
was associated with lower levels of these variables.   In regressions, greater social support 
was shown to be a significant predictor of less anxiety, anger, depression and loneliness.  
Furthermore, greater social support was also found to be a significant predictor of better 
mental health aspects of health-related quality of life, postpartum emotional well-being and 
self-esteem.  These findings were still significant when other demographic, clinical and 
psychological variables were included in the model.   
Conversely, the results were not consistent with the indirect pathway through 
individual coping resources proposed by Heaney and Israel (2008), as non-significant 
correlations were identified for the only variable included in this pathway: problem-focused 
coping (O’Brien, 1993).  Non-significant findings were also reported in two studies at 
regression, these were for psychosocial adjustment (Sullivan et al., 2004), and for depression 





and tension (anger and anxiety) in male participants (McCabe et al., 2004) which were 
included in the direct pathway.   
Some of these findings were stronger than others, as some of these relationships were 
only identified in one or two studies (anxiety, anger, loneliness, hope, mental health status, 
postpartum, psychological adjustment and self-esteem).  However, the relationship with other 
variables such as depression and mental aspects of health-related quality of life were 
identified in multiple studies, with depression being studied the most frequently.  
Furthermore, various effect sizes were reported, with the largest effect sizes identified for 
studies that assessed depression, hope, mental aspects of health-related quality of life and 
postpartum emotional distress.  However, not all the studies assessing depression and mental 
aspects of health-related quality of life identified large effect sizes, as some reported small 
and medium effect sizes and one study (McCabe et al. 2004) reported non-significant results 
for male participants at regression.  Due to the longitudinal aspects of the study assessing 
postpartum emotional distress (Gulick & Kim, 2004), the effect sizes also varied at the 
different time points and included small and medium effect sizes too.  Moreover, those 
studies using a correlational design only, have less strength than those reporting regressions.  
Therefore, when considering all the aspects relating to the strength of these findings, 
depression followed by mental aspects of health-related quality of life appear to be the 
strongest.  These had large effect sizes at correlation, were also found to be significantly 
predicted by social support at regression and were assessed by multiple studies.  Mental 
aspects of health-related quality of life and depression also had some of the highest quality 
assessment ratings.   
The current findings are similar to those found by Dennison et al. (2009) whose 
definition of adjustment included psychological well-being; therefore, variables that this 
review considered as evidence of ‘adjustment’ were also included here.  This included 





variables such as anger, anxiety, depression and mental aspects of health-related quality of 
life.  Social support was identified as a significant predictor of these variables, as they were in 
the Dennison et al. (2009) review.  The present review builds on this, incorporating more up 
to date research as only three studies in the present review overlapped with theirs (McCabe et 
al., 2004; McIvor et al., 1984; Schwartz & Frohner, 2005).    
Depression is another variable included in the current review that previous research 
has identified as a correlate of social support.  A review of depression in MS (Arnett et al. 
2008) identified a consistent relationship between social support and depression, therefore the 
results of this review are congruent with and update these findings.  Only two of the eight 
depression studies included in the current review (Chwastiak et al., 2002; McIvor et al., 1984) 
were included in the Arnett et al, (2008) review.    
These findings are congruent with other theoretical perspectives of social support, 
such as the stress, social support, and the buffering hypothesis, proposed by Cohen and Wills 
(1985).  This puts forward two models to account for the process through which social 
support has a positive impact on well-being in the context of physical health conditions; the 
main effects and stress buffer models.   The main effects model suggests that social support 
could be beneficial to psychological and health outcomes due to the individual regularly 
receiving positive experiences and gaining socially rewarded roles in the community.  This 
can in turn promote positive affect, predictability, stability and an enhancement of self-worth.   
The stress buffer model suggests that stress can be experienced as a result of illness, failures 
in self-care and by disruptions to the neuroendocrine or immune system functioning.  This 
stress can contribute to negative affect, increase in physiological responses, behavioural 
adaptations, feelings of helplessness and reductions in self-esteem.   This model suggests that 
social support can influence the negative impacts of stress at two points in the causal chain 
between stress and illness.  Social support could mediate between the stressful (or anticipated 





stressful) event and the stress reaction by preventing a stress appraisal response.  
Alternatively, sufficient support could mediate between the experience of stress and the 
resulting physiological response by reducing the stress reaction or directly affecting the 
physiological processes.  The findings from this review are congruent with the main effects 
model, however, more research is needed to explore the mechanisms through which this 
relationship is produced.  Further research using more complex models would be beneficial to 
explore the complex relationship that social support has on improving psychological distress 
and enhancing well-being for individuals experiencing physical health conditions, including 
MS.   
Strengths and Limitations of the Current Review 
 Although the majority of studies (n = 13) were conducted in the USA, this review was 
able to include studies from several countries, which increases generalisability.  Another 
strength of this review is in terms of the populations used within the studies, as a good range 
of populations were included, such as; hospitalised, non-hospitalised, spinal form MS, 
RRMS, mothers, women and veterans. 
 One limitation regards the diagnosis of MS, as no exclusion criteria was set for this.  
Nine of the studies (43%) used self-report to determine this which could allow for individuals 
who may not have a definite diagnosis of MS to participate, potentially reducing the validity 
of the sample.   
A further consideration regards the measure used to conceptualise loneliness in the 
Beal and Stuifbergen (2007) study.  To measure loneliness, they used one question from the 
CES-D “I felt lonely”, although this is not a specific measure of loneliness, making this less 
psychometrically robust.  However, this question was taken from a reliable and valid measure 
and this question had been designed to measure loneliness as a part of this measure.  A 
similar question of loneliness was found to highly correlate with the Revised UCLA 





Loneliness Scale (Russell, Peplau & Cutrona, 1980) which is a widely used measure of 
loneliness in research.   
Clinical Implications 
 These findings highlight the important role that social support can have in predicting 
psychological outcomes in individuals with MS.  The outcome with the most prominent 
relationship with social support was depression, and research has estimated lifetime 
prevalence rates of major depression of up to 50% for individuals with MS (Feinstein, 2011).    
It would therefore be useful for clinicians working with individuals with MS who are 
experiencing psychological distress, such as depression, to establish an individuals’ levels of 
perceived social support when assessing their psychological needs.  Social support 
interventions, such as peer support, have been found to be beneficial in reducing levels of 
depression in mental health populations (see meta-analysis by Pfeiffer, Heisler, Piette, Rogers 
& Valenstein, 2011).   
 Research investigating the effectiveness of social support interventions for individuals 
with MS is limited.  One review of social support interventions in a variety of populations 
was conducted by Hogan, Linden and Najarian (2002), who identified some findings that 
supported their use.  This included research conducted by Maton (1988), which included 
participants who had attended a MS peer support group and found that those providing 
support and those who both provided and received support reported higher levels of well-
being.  Ng, Amatya, and Khan (2013) evaluated the impact of a peer support programme on 
improving MS psychological functioning (depression, anxiety and stress).  Participants 
reported improved psychological functioning and quality of life six weeks following the 
programme, and positive improvements in stress and quality of life were maintained at 12 
months follow up.  However, Uccelli, Mohr, Battaglia, Zagami and Mohr (2004) assessed the 
effectiveness of peer support groups in MS and found that attendance at support groups did 





not improve depression or quality of life.  Moreover, those who had better mental health 
functioning could be at risk of deterioration by accessing the group.  Thus, further research is 
required to understand the best way of offering social support, as the current literature is 
unclear. 
Future Research 
Some variables included in this review were only investigated by one study (anger, 
coping, hope, loneliness, mental health status, postpartum emotional distress and 
psychological adjustment) so further research in these areas would help to enhance the 
strength of the relationships found.  Anxiety was also studied infrequently, and this is 
especially important as anxiety is common in MS but is often over-looked and under-treated 
(Korostil & Feinstein, 2007).  Anger has also been identified as an important psychological 
variable for individuals with a diagnosis of MS, as levels of anger have been found to be 
higher or lower than in the general population (Nocentini et al., 2009).  These levels of anger 
were found to be mainly independent of mood and the authors suggest this may have a 
physiological cause.  Therefore, further exploration of these variables would benefit the 
understanding and resulting management of these difficulties.   
 Only three of the studies included in this review (Bambara et al., 2011; Chwastiak et 
al., 2002; Sullivan et al., 2004) assessed the differences between outcome measure scores and 
the type of MS.  Chwastiak et al. (2002) identified no significant difference between the 
mean depression scores of three subtypes of MS (relapsing-remitting, primary progressive 
and secondary progressive).  However, Bambara et al. (2011) found that those with a 
diagnosis of progressive MS had higher levels of depression than those with a relapsing-
remitting subtype.  This was supported by Sullivan et al. (2004) as they identified that those 
in remission had significantly better levels of adjustment than those in exacerbation or with 
the secondary-progressive subtype (there was no difference identified between those in 





exacerbation and those with secondary-progressive subtype).   As these studies highlight, 
some significant differences between the subtypes of MS can occur, and by including and 
comparing the different subtypes within the samples and including these within regression 
analyses, strengthen their findings.  Including this comparison within future research would 
help to establish whether a certain subtype has a stronger relationship to psychological 
distress than another.   
Furthermore, investigating the mechanisms of how social support influences well-
being would also be beneficial to understand how better to support people once difficulties 
have been identified.  More longitudinal studies are required as only two studies using a 
longitudinal design were identified in this review (Gulick & Kim, 2004; Koelmel et al., 
2017).  More complex models such as those conducted by Koelmel et al., (2017) whereby the 
effect that social support had on mental health outcomes at subsequent time-points by using a 
linear mixed-effects regression analyses would enhance future findings. 
Conclusion 
 The results of this systematic literature review provide evidence for some significant 
relationships between perceived social support and anxiety, anger, depression, hope, 
loneliness, mental aspects of health-related quality of life, mental health outcomes, 
postpartum emotional distress, self-esteem and psychological adjustment in individuals with 
a diagnosis of MS.  However, most of the research is cross-sectional, many studies are only 
correlational and limited research exists on certain variables.  Useful implications for clinical 
practice, such as highlighting the relationship between social support and psychological 
outcomes and facilitating access and receipt of this could enhance individual’s psychological 
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database searching 



























Additional records identified 
through other sources 
(n = 2) 
Records after duplicates removed  
(n = 435)  
Then screened by title 
Records screened by 
abstract  
(n = 202) 
Records excluded as they 
were not relevant 
(n = 233) 
Full-text articles assessed 
for eligibility 
(n = 53) 
Full-text articles excluded, as 
they were not investigating 
psychological correlates of 
social support specifically, 
presentation abstracts, review 
articles, the wrong construct 
of social support, not available 
in English, thesis papers or 
caregiver focused 
(n = 32) 
Studies included in 
quantitative review 
(n = 21) 
Records excluded; as they were 
not investigating psychological 
correlates of social support, 
caregiver focused, not specific to 
MS, commentary articles, 
qualitative studies, systematic 
reviews, or wrong construct of 
social support 
(n = 149) 
 





Table 1: Quality assessment ratings (NICE, 2018) 





al. (2011)  
+ + + NA ++ NA ++ + ++ NA NA NA ++ ++ ++ ++ ++ + 
 Bamer et al. 
(2008) 




+ + + NA ++ NA + + NR NA NA NA ++ + + ++ + + 
Chwastiak et 
al. (2002) 
+ + + NA + NA ++ + NR NA NA NA ++ ++ ++ ++ ++ + 
Costa et al. 
(2012) 




+ + + NA ++ NA + + ++ NA NA NA - + + ++ + + 
Effat et al. 
(2016) 
+ + + NA + NA -  + NR NA NA NA - ++ - ++ + + 
Farran et al. 
(2016) 
++ ++ + NA + NA - + NR NA NA NA - ++ - ++ + ++ 
Foote et al. 
(1990) 
+ ++ ++ NA ++ NA - + ++ NA NA NA - - - ++ - ++ 
Gay et al. 
(2010) 
+ + + NA ++ NA - + NR NA NA NA + ++ - ++ + + 
Gulick and 
Kim (2004) 




+ + + NA ++ NA + + NR NA NA NA ++ + + ++ + + 









Hyarat et al. 
(2018) 
+ ++ + NA ++ NA - + NR NA NA NA ++ + - ++ + + 
Jaracz et al. 
(2010) 
++ + + ++ ++ NA ++ + NR NA NA NA ++ ++ ++ ++ ++ + 
Koelmel et 
al. (2017) 
+ + + ++ + ++ ++ + + NR ++ ++ ++ ++ ++ ++ ++ + 
McCabe et 
al. (2004) 
+ + + ++ ++ NA ++ + NR 
 
NA NA NA ++ ++ ++ NR ++ + 
McIvor et al. 
(1984) 
+ + + NA ++ NA ++ + NR NA NA NA + + + ++ + + 
O’Brien 
(1993) 




+ ++ ++ NA ++ NA ++ + NR NA NA NA - ++ ++ ++ ++ ++ 
Suh et al. 
(2012) 
+ + + NA ++ NA + + NR NA NA NA ++ + + ++ + + 
Sullivan et al. 
(2004) 
+ + + NA + NA ++ + ++ NA NA NA + ++ ++ + ++ + 
 
 
Questions: The NICE quality appraisal checklist – quantitative studies reporting correlations and associations (p. 200 - 205; 2018) 
 Section 1: Population 
1.1 - Is the source population or source area well described? 
1.2 - Is the eligible population or area representative of the source population? 
1.3 - Do the selected participants or areas represent the eligible population or area? 
 





Section 2: Method of selection of exposure (or comparison) group 
 
2.1 - Selection of exposure (and comparison) group.  How was selection bias minimised? 
2.2 - Was the selection of explanatory variables based on a sound theoretical basis? 
2.3 - Was the contamination acceptably low? 
2.4 - How well were likely confounding factors identified and controlled? 
2.5 - Is the setting applicable to the UK? 
 
 Section 3: Outcomes 
 
3.1 - Were the outcome measures and procedures reliable? 
3.2 - Were the outcome measurements complete? 
3.3 - Were all important outcomes assessed? 
3.4 - Was there a similar follow-up time in exposure and comparison groups? 
3.5 - Was follow-up time meaningful? 
 
 Section 4: Analyses 
 
4.1 - Was the study sufficiently powered to detect an intervention effect (if one exists)? 
4.2 - Were multiple explanatory variables considered in the analyses?   
4.3 - Were the analytical methods appropriate? 
4.6 - Was the precision of association given or calculable?  Is association meaningful? 
 
Section 5: Summary 
 
5.1 - Are the study results internally valid (i.e. unbiased)? – Total Internal Validity 
5.2 - Are the findings generalisable to the source population (i.e. externally valid)? – Total External Validity 
 
Scale 
++ indicates that for that particular aspect of study design, the study has been designed or conducted in such a way to minimise the risk of bias. 
 





+ indicates that either the answer to the checklist question is not clear from the way the study is reported, or that the study may not have 
addressed all potential sources of bias for that particular aspect of study design. 
-  should be reserved for those aspects of the study design in which significant sources of bias may persist. 
NR not reported should be reserved for those aspects in which the study under review fails to report how they have (or might have) been 
considered. 






















Table 2: Articles included in the review 
 


















































total social support 
were significantly 
related to 
depression (r = -
0.20, p < 0.001; r 
= -0.14, p < 0.001; 
r = 0.20, p < 




















living situation (β 
= -0.24, p < 0.001) 
Bamer et 















































































higher levels of 
depression on the 
CES-D (ᵡ² = 54.91, 
p < 0.001; Odds 
Ratio = 1.99; 95% 
CI = 1.66-2.39) 
 
Eastern Sample: 




higher levels of 
depression on the 
CES-D (ᵡ² = 30.36, 
p < 0.001; Odds 
Ratio = 1.85; 95% 
CI = 1.49-2.31) 
 






















































































social support and 
loneliness (r = -
0.45, p < 0.01) 
 
Regression: 
Social support was 
found to be a 
significant 
predictor of 
loneliness (β = -
0.34, p < 0.05) 

























































higher levels of 
depression on the 
CES-D (ᵡ² = 49.5, 
p = 0.001; Odds 
Ratio = 1.92; 95% 
CI = 1.60-2.30)  





























quality of life 
Demographic








component of the 
MSSS produced a 
statistically 
significant change 





components of the 











dimension of the 
SF-36v2 (β = 
0.290, p = 0.000; β 
= 0.336, p = 0.000; 
β = 0.214, p = 
0.003; β = 0.447, p 
= 0.000 




reported for the 
material support 



















sample from a 
large database 
of individuals 





























social support and 
self-esteem (r = 
0.366, p <0.01) 
 
Regression: 




esteem (β = 0.411, 
p = 0.004) 





















































quality of life 
two of the mental 
components 
(vitality and 
mental health) of 
the MSQLI (r = 
0.333, p < 0.01; r 

















































Social support was 
positively 
correlated with 
QoL (r = 0.728, p 
< 0.001) 








mean age 36)  
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south-eastern 
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both hope and 
self-esteem (r = 
0.6848, p < 0.001; 
r = 0.4352, p < 
0.01) 
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at 1 month 
postpartum (r = 
0.50, p < 0.01; r = 
-0.34, p <0.01; r = 
0.20, p < 0.01 
respectively); 3 
months (r = 0.43, 
p < 0.01; r = 0.34, 
p < 0.01; r = 0.21, 
p < 0.01 
respectively); 6 
months (r = 0.49, 
p < 0.01; r = 0.39, 
p < 0.01; r = 0.31, 
p < 0.01 
respectively)   
 











distress at all three 
timepoints (β = 
0.34, p < 0.001; β 
= 0.23, p < 0.01; β 
= 0.38, p < 0.001 






























mean age 43, 
range 22-74; 
ethnicity: 








































depression (r = -
0.49, p < 0.01) 
 
Regression: 
Social support was 
found to be a 
significant 
predictor of 
depression (β = -
0.43, p < 0.001) 
Hyarat et 





























found between all 
aspects of the 
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and friend support 
subscale) and 
depression scores 
(r = -0.81, p < 
0.005; r = -0.82, p 
< 0.005, r = -0.63, 
p < 0.005 
respectively) 





























































and total score) 
positively 
correlated with 
MHQOL (r = 
0.31, p < 0.01; r = 
0.25, p < 0.01; r = 
0.21, p < 0.01; r = 
0.34, p < 0.01; r = 
0.23, p < 0.01; r = 
0.24, p < 0.01; r = 
0.33, p < 0.01 
respectively) 
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support was a 
significant 
predictor of 
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found between all 




and friends) and 
depression at 
baseline (r = -0.19, 
p < 0.05, r = -0.24, 
p < 0.01, r = -0.20, 
p < 0.05 
respectively).  
This was only 
partially supported 
at 26 weeks as 
support from 






was no longer 
significant (r = -
0.19, p < 0.05, r = 





found at 52 weeks 
(r = -0.23, p < 
0.01, r = -0.19, p < 
0.05, r = -0.20, p < 






and friends types 
of social support 
and anxiety at 
baseline (r = -0.17, 
p < 0.05, r = -0.16, 
p < 0.05 
respectively) 
however at 26 and 






component (r = -
0.24, p < 0.01, r = 















health status at 
baseline (r = 0.18, 
p < 0.05, r = 0.23, 
p < 0.01 
respectively).  All 
components were 
found to be 
statistically 
significant at 26 
weeks (r = 0.30, p 
< 0.001, r = 0.20, 
p < 0.05, r = 0.19, 
p < 0.05 
respectively).  At 




significant (r = 
0.25, p < 0.01, r = 













on general mental 








Depression (β = -
0.18, p < 0.001, 
95% CI = -0.86 to 
-0.26; β = -0.23, p 
< 0.001, 95% CI = 
-1.02 to -0.42; β = 
-0.20, p < 0.01, 
95% CI = -00.95 





Anxiety (β = -
0.16, p < 0.001, 
95% CI = -1.55 to 
-0.45; β = -0.19, p 
< 0.001, 95% CI = 
-1.71 to – 0.57; β 
= -0.17, p < 0.001, 
95% CI = -1.73 to 
-0.52 for 
significant others, 









health status (β = 
0.18, p < 0.001, 
95% CI = -0.07 to 
0.19; β = 0.18, p < 
0.001, 95% CI = 
0.52 to 1.80; β = 
0.11, p = 0.03, 
95% CI = 0.07 to 
















































































components of the 
POMS-SF (β = -
0.16, p < 0.05 β = 
-0.19, p < 0.01 
respectively). 
MS Males: Social 
support was not 
found to be a 
significant 
predictor of 
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New York 






























family and friends) 
and depression 
were statistically 
significant (r = -
0.60, p < 0.001; r 
















































social support and 
problem-focused 
coping (r = 0.126)   
































































social support and 
MHQOL (r = 
0.58, p < 0.01) 
 
Regression: 




all of the other 
variables (β = 0.4, 
p < 0.01) 














































social support and 
the HADS (r = -
0.386, p < 0.001) 
 














depression (β = -
0.37, p = 0.0001) 
for step one and β 
= -0.14, p = 0.05 
for step two (when 
mobility disability 
and perceived 











































































social support and 
adjustment (r = -
0.22, p < 0.05) 
 
Regression: 
Social support was 




adjustment (β = -
0.12) 








*The data included in the Bamer et al. (2008) study includes a ‘western sample’ which is the same data set as the study conducted by Chwastiak et al. (2002) 
study.  However, the Bamer et al. (2008) study also includes an ‘eastern sample’ of new data for comparison and therefore the studies have been reported 
separately.   
 
**The data included in the Beal and Stuifbergen (2007) study is from the same pool of data as the Harrison and Stuifbergen (2002) study.  However, the Beal 
and Stuifbergen study looked at a specific aspect of the CES-D (loneliness) and therefore the studies have been reported separately.   
 
***The response rates for these studies were not directly provided in the paper but were calculable from the details provided.  These response rates were 
calculated by determining the percentage of responses received from the number of requests sent (the number of ineligible participants was removed from 
both the number sent and returned, and the number of those who declined to participate were deducted from the amount received). 
 
Note: MSSS = Medical Outcomes Study Modified Social Support Scale; M-PS = Mobility subscale of the Performance Scales; PHQ-9 = Patient Health 
Questionnaire; EDSS = Expanded Disability Status Scale; CES-D = Center for Epidemiological Studies Depression Scale; PRQ = Personal Resource 
Questionnaire; ISS = Incapacity Status Scale; MAI = Multilevel Assessment Inventory; DOII = Demands of Illness Inventory; SF36v2 = Medical Outcome 
Study 36-Item Health Survey Short Form (adapted to Portuguese); SPS = Social Provisions Scale; RSES = Rosenberg Self-Esteem Scale; MSIS-29 = 29-item 
Multiple Sclerosis Impact Scale; PDDS = Patient Determined Disease Steps; BDI = Beck Depression Inventory; MSQLI = Multiple Sclerosis Quality of Life 
Inventory; MusiQol – Multiple Sclerosis International Quality of Life Questionnaire; BDI-II = Beck Depression Inventory II; BAI = Beck Anxiety 
Inventory; FSS = Fatigue Severity Scale; MHS = Miller Hope Scale; SSQ-6 = Social Support Questionnaire; DSRS = Depression Self-Rating Scale; STAI = 
State and Trait Anxiety Inventory; SEI – Self-Esteem Inventory; TAS 20 = Toronto Alexithymia Scale; CHIP = Coping about Health Injuries and Problems; 
MSRS = MS-Related Scale; MSRSS = MS-Related Symptom Scale; PSQ = Postpartum Support Questionnaire; PRQ 85 = Personal Resource Questionnaire; 
CCS = Concern for Children Scale; CESD-10; Center for Epidemiological Studies Depression 10-item scale); MSPSS – Multidimensional Scale of 
Perceived Social Support; MSQOL-54 = Multiple Sclerosis Quality of Life Scale; C-DRS = Connor-Davidson Resilience Scale; ED-A = Emotional Distress-
Anxiety Scale; MCS = Mental Component Summary; SSF-WHOQOL-100 = Social Support Facet of World Health Organisation Quality of Life-100 Scale; 
WOCQ = Ways of Coping Questionnaire; POMS-SF = Profile of Mood States-Short Form; PSSI – Family-based and Friend-based = Perceived Social 
Support Inventory – Family-based and Friend-based; WAIS = Wechsler Adult Intelligence Scale (vocabulary subtest); NSSQ = Norbeck Social Support 
Questionnaire; WCC = Ways of Coping Checklist; TSCS = Tennessee Self-Concept Scale; HADS = Hospital Anxiety and Depression Scale; GLTEQ = 
Godin Leisure-Time Exercise Questionnaire; PSS = Perceived Stress Scale; COPE = COPE Inventory; PAIS = Psychosocial Adjustment to Illness Scale; 










Appendix 1-A: PRIMSA (2009) Checklist 
 
Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.   
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; 
conclusions and implications of key findings; systematic review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.   
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 




10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
 





Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).   
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
 
 
Page 1 of 2  
Section/topic  # Checklist item  
Reported on 
page #  
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).   
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for 
each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.   
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).   
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see 
Item 16]).  
 





DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of 
funders for the systematic review.  
 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): 
e1000097. doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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Appendix 1-C: Quality Assessment Scoring Description 
• A score of ++ suggests that the aspect of study design has been conducted to minimise 
the risk of bias. 
• A score of + suggests that the answer to the checklist was either not clear from the 
reporting of the study, or that all potential sources of bias for that aspect of design 
may not have been addressed. 
• A score of - showed that the aspect of study design contained significant sources of 
bias which may endure. 
• A score of NR (not reported) suggests that the aspect of design being reviewed failed 
to report how they have (or might have) been considered. 
• A score of NA (not applicable) suggests that the aspect of design being reviewed was 
not applicable given the study design.   
For the final two summary questions there are three possible responses:  
• A score of ++ suggests that all or most of the checklist criteria were fulfilled, or 
conclusions are very unlikely to alter. 
• A score of + suggests that some of the checklist criteria have been fulfilled or that the 
conclusions are unlikely to alter. 
• A score of - suggests that few or no checklist criteria were fulfilled and conclusions 










Appendix 1-D: Excluded Articles 
Study Reason for Exclusion 
Anagnostouli, M., Katsavos, S., Artemiadis, A., Zacharis, M., Argirou, P., 
Theotoka, I., ... & Stamboulis, E. (2014). Determinants of stigma 
experienced by patients suffering from multiple sclerosis. A 




social support and 
psychological variable 
Anens, E., Zetterberg, L., Urell, C., Emtner, M., & Hellström, K. (2017). 
Self-reported physical activity correlates in Swedish adults with 




social support and 
psychological variable 
Arnett, P. A., Barwick, F. H., & Beeney, J. E. (2008). Depression in 
multiple sclerosis: review and theoretical proposal. Journal of the 
International Neuropsychological Society, 14(5), 691-724. 
Review paper 
Briones-Buixassa, L., Milà, R., Aragonès, J. M., Bufill, E., & Arrufat, F. 
X. (2015). The role of psychosocial moderator factors in the 
relationship between stress and multiple sclerosis: a case-control 
study. Psychotherapy & Psychosomatics, 84(supplement 1), 10. 
Conference paper 
Cadden, M. H., Arnett, P. A., Tyry, T. M., & Cook, J. E. (2018). Judgment 
hurts: The psychological consequences of experiencing stigma in 
multiple sclerosis. Social Science & Medicine, 208, 158-164. 
Not assessing 
relationship between 
social support and 
psychological variable 
Gatten, C. W., Brookings, J. B., & Bolton, B. (1993). Mood fluctuations in 
female multiple sclerosis patients. Social Behavior & Personality: 
an International Journal, 21(2), 103-106. 
Wrong construct of 
social support 
Geertz, W., Dechow, A. S., Patra, S., Heesen, C., Gold, S. M., & Schulz, 
K. H. (2015). Changes of motivational variables in patients with 
multiple sclerosis in an exercise intervention: associations between 
physical performance and motivational determinants. Behavioural 
Neurology, 2015(248193), 7 pages. 
Wrong construct of 
social support 
Gulick, E. E. (2001). Emotional distress and activities of daily living 
functioning in persons with multiple sclerosis. Nursing 
Research, 50(3), 147-154. 
Wrong construct of 
social support 
Hoover, M. H. (2005). The relationship between stress and 
symptomatology of Multiple Sclerosis moderated by perceived 
marital support. ProQuest Information & Learning, 66, 1776 
Wrong construct of 
social support 
Hwang, J. E., Cvitanovich, D. C., Doroski, E. K., & Vajarakitipongse, J. G. 
(2011). Correlations between quality of life and adaptation factors 
among people with multiple sclerosis. American Journal of 
Occupational Therapy, 65(6), 661-669. 
Wrong construct of 
social support 
James, E., Mills, R. J., Tennant, A., & Young, C. A. (2016). Identification 
of coping strategies in Multiple Sclerosis. Multiple Sclerosis, 
22(supplement 3), 432 
Conference paper 
Kisvetrova, H., Kralova, J. (2014). Basic factors influencing death anxiety. 
Ceskoslovenska Psychologie, 58(1), 41-51 
Not in English 
Kleiboer, A. M., Kuijer, R. G., Hox, J. J., Jongen, P. J., Frequin, S. T., & 
Bensing, J. M. (2007). Daily negative interactions and mood among 
patients and partners dealing with multiple sclerosis (MS): The 
Wrong construct of 
social support 





moderating effects of emotional support. Social Science & 
Medicine, 64(2), 389-400. 
Korostil, M., & Feinstein, A. (2007). Anxiety disorders and their clinical 
correlates in multiple sclerosis patients. Multiple Sclerosis 
Journal, 13(1), 67-72. 
Wrong construct of 
social support 
Long, D. D., & Miller, B. J. (1991). Suicidal tendency and multiple 
sclerosis. Health & Social Work, 16(2), 104-109. 
Wrong construct of 
social support 
Maybury, C. P., & Brewin, C. R. (1984). Social relationships, knowledge 
and adjustment to multiple sclerosis. Journal of Neurology, 
Neurosurgery & Psychiatry, 47(4), 372-376. 
Not assessing 
relationship between 
social support and 
psychological variable 
Mohr, D. C., Classen, C., & Barrera, M. (2004). The relationship between 
social support, depression and treatment for depression in people 
with multiple sclerosis. Psychological Medicine, 34(3), 533-541. 
Not assessing 
relationship between 
social support and 
psychological variable 
Montanari, E., Pattini, M., Cenci, F., Pesci, I., Manneschi, L., Guareschi, 
A. … Marta, E. (2009). Quality of life in multiple sclerosis: Social 




Paddam, A., Barnes, D., Langdon, D. (2009). Why are multiple sclerosis 
patients angry? A preliminary quantitative study of factors 
associated with anger in multiple sclerosis. Multiple Sclerosis, 15(9: 
Supplement S), S228 
 
Presentation abstract 
Pattini, M., Cenci, F., Allegri, B., Pesci, I., Manneschi, L., Guareschi, A. 
… Montanari, E. (2010). Quality of life in multiple sclerosis: Social 
support, depression, personality and coping style. Multiple 
Sclerosis, 16(10: Supplement 1), S180-S181 
Presentation abstract 
Phillips, L. J., & Stuifbergen, A. K. (2010). The relevance of depressive 
symptoms and social support to disability in women with multiple 
sclerosis or fibromyalgia. International Journal of Rehabilitation 
Research, 33(2), 142. 
Not assessing 
relationship between 
social support and 
psychological variable 
Rommer, P. S., Sühnel, A., König, N., & Zettl, U. K. (2017). Coping with 
multiple sclerosis—the role of social support. Acta Neurologica 
Scandinavica, 136(1), 11-16. 
Wrong construct of 
social support 
Siegel, S. D., Turner, A. P., & Haselkorn, J. K. (2008). Adherence to 
disease-modifying therapies in multiple sclerosis: does caregiver 
social support matter?. Rehabilitation Psychology, 53(1), 73. 
Wrong construct of 
social support 
Strober, L. B. (2016). A biopsychosocial approach to understanding quality 
of life in early onset multiple sclerosis (MS). Quality of Life 
Research, 25(1: Supplement 1), 152. 
Conference paper 
Strober, L. B. (2018). Quality of life and psychological well-being in the 
early stages of multiple sclerosis (MS): Importance of adopting a 




social support and 
psychological variable 
Terzi, M., Sen, S., Kumcagiz, H., Terzi, Y. (2018). Variables that affect 
life satisfaction of multiple sclerosis patients a comparative study. 
Multiple Sclerosis Journal, 24(3), 387. 
Conference paper 
Warren, S., Warren, K. G., & Cockerill, R. (1991). Emotional stress and 
coping in multiple sclerosis (MS) exacerbations. Journal of 
Not assessing 
relationship between 





Psychosomatic Research, 35(1), 37-47. social support and 
psychological variable 
Wilski, M., Tomczak, M. (2016). Illness perception in multiple sclerosis. 
Sociodemographic, illness-related, and psychosocial correlates. 









Wineman, N. M. (1990). Adaptation to multiple sclerosis: the role of social 
support, functional disability, and perceived uncertainty. Nursing 
research, 39(5), 294-299 
Wrong construct of 
social support 
Wollin, J. A., Fulcher, G., McDonald, E., Spencer, N., Mortlock, M. Y., 
Bourne, M., & Simmons, R. D. (2010). Psychosocial factors that 
influence quality of life and potential for self-management in 
multiple sclerosis. International Journal of MS Care, 12(3), 133-
141. 
Wrong construct of 
social support 
Wollin, J. A., Spencer, N., McDonald, E., Fulcher, G., Bourne, M., & 
Simmons, R. D. (2013). Longitudinal changes in quality of life and 
related psychosocial variables in Australians with multiple 
sclerosis. International Journal of MS Care, 15(2), 90-97. 
Wrong construct of 
social support 
Yamout, B., Issa, Z., Herlopian, A., El Bejjani, M., Khalifa, A., Ghadieh, 
A. S., & Habib, R. H. (2013). Predictors of quality of life among 
multiple sclerosis patients: a comprehensive analysis. European 
Journal of Neurology, 20(5), 756-764. 

















Appendix 1-E: Duplicate Samples 
Four studies used the same data sets within the studies; the data included in the Bamer 
et al. (2008) study includes a ‘western sample’ (n = 661) which is from the same data set as 
the study conducted by Chwastiak et al. (2002) study.  However, the Bamer et al. (2008) 
study also includes an ‘eastern sample’ of new data for comparison and therefore the studies 
have been reported separately.  Moreover, the data included in the Beal and Stuifbergen 
(2007) study (n = 659) is from the same pool of data as the Harrison and Stuifbergen (2002) 
study.  However, the Beal and Stuifbergen (2007) study looked at a specific aspect of the 
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 BJHP AUTHOR GUIDELINES 
Sections 
1. Submission 
2. Aims and Scope 
3. Manuscript Categories and Requirements 
4. Preparing the Submission 
5. Editorial Policies and Ethical Considerations 
6. Author Licensing 
7. Publication Process After Acceptance 
8. Post Publication 
9. Editorial Office Contact Details 
1. SUBMISSION 
Authors should kindly note that submission implies that the content has not been published or 
submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific 
meeting or symposium. 
Once the submission materials have been prepared in accordance with the Author 
Guidelines, manuscripts should be submitted online 
at http://www.editorialmanager.com/bjhp 
Click here for more details on how to use Editorial Manager. 
All papers published in the British Journal of Health Psychology are eligible for Panel A: 
Psychology, Psychiatry and Neuroscience in the Research Excellence Framework (REF). 
Data protection: 
By submitting a manuscript to or reviewing for this publication, your name, email address, and 
affiliation, and other contact details the publication might require, will be used for the regular 
operations of the publication, including, when necessary, sharing with the publisher (Wiley) and 
partners for production and publication. The publication and the publisher recognize the 
importance of protecting the personal information collected from users in the operation of these 
services, and have practices in place to ensure that steps are taken to maintain the security, 
integrity, and privacy of the personal data collected and processed. You can learn more 
at https://authorservices.wiley.com/statements/data-protection-policy.html. 
Preprint policy: 
This journal will consider for review articles previously available as preprints on non-commercial 
servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the 
submitted version of a manuscript to non-commercial servers at any time. Authors are requested 
to update any pre-publication versions with a link to the final published article. 
2. AIMS AND SCOPE 
The British Journal of Health Psychology publishes original research on all aspects of psychology 
related to health, health-related behaviour and illness across the lifespan including: 
• experimental and clinical research on aetiology 





• management of acute and chronic illness 
• responses to ill-health 
• screening and medical procedures 
• psychosocial mediators of health-related behaviours 
• influence of emotion on health and health-related behaviours 
• psychosocial processes relevant to disease outcomes 
• psychological interventions in health and disease 
• emotional and behavioural responses to ill health, screening and medical procedures 
• psychological aspects of prevention 
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS 
The types of paper invited are: 
• papers reporting original empirical investigations, using either quantitative or qualitative 
methods, including reports of interventions in clinical and non-clinical populations; 
• theoretical papers which report analyses on established theories in health psychology; 
• we particularly welcome review papers, which should aim to provide systematic 
overviews, evaluations and interpretations of research in a given field of health 
psychology (narrative reviews will only be considered for editorials or important 
theoretical discourses); and 
• methodological papers dealing with methodological issues of particular relevance to 
health psychology. 
Authors who are interested in submitting papers that do not fit into these categories are advised 
to contact the editors who would be very happy to discuss the potential submission. 
Papers describing quantitative research (including reviews with quantitative analyses) should be 
no more than 5000 words (excluding the abstract, reference list, tables and figures). Papers 
describing qualitative research (including reviews with qualitative analyses) should be no more 
than 6000 words (including quotes, whether in the text or in tables, but excluding the abstract, 
tables, figures and references). In exceptional cases the Editor retains discretion to publish 
papers beyond this length where the clear and concise expression of the scientific content 
requires greater length (e.g., explanation of a new theory or a substantially new method). Authors 
must contact the Editor prior to submission in such a case. 
All systematic reviews must be pre-registered. The pre-registered details should be given in the 
methods section but blinded for peer review (i.e., ‘the review was preregistered at [BLINDED]’); 
the details can be added at proof stage. Registration documents should be uploaded as title 
page files when possible, so that they are available to the Editor but not to reviewers. 
Please refer to the separate guidelines for Registered Reports. 
4. PREPARING THE SUBMISSION 
Contributions must be typed in double spacing. All sheets must be numbered. 
Cover Letters 
Cover letters are not mandatory; however, they may be supplied at the author’s discretion. They 
should be pasted into the ‘Comments’ box in Editorial Manager. 
Parts of the Manuscript 
The manuscript should be submitted in separate files: title page; statement of contribution; main 
text file; figures/tables; supporting information. 
Title Page 





You may like to use this template for your title page. The title page should contain: 
• A short informative title containing the major key words. The title should not contain 
abbreviations (see Wiley's best practice SEO tips); 
• A short running title of less than 40 characters; 
• The full names of the authors; 
• The author's institutional affiliations where the work was conducted, with a footnote for 





Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations 
section for details on author listing eligibility. When entering the author names into Editorial 
Manager, the corresponding author will be asked to provide a CRediT contributor role to classify 
the role that each author played in creating the manuscript. Please see the Project 
CRediT website for a list of roles. 
Abstract 
For articles containing original scientific research, a structured abstract of up to 250 words should 
be included with the headings: Objectives, Design, Methods, Results, Conclusions. Review 
articles should use these headings: Purpose, Methods, Results, Conclusions. As the abstract is 
often the most widely visible part of your paper, it is important that it conveys succinctly all the 
most important features of your study. You can save words by writing short, direct sentences. 
Helpful hints about writing the conclusions to abstracts can be found here. 
Keywords 
Please provide appropriate keywords. 
Acknowledgments 
Contributions from anyone who does not meet the criteria for authorship should be listed, with 
permission from the contributor, in an Acknowledgments section. Financial and material support 
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Statement of Contribution 
All authors are required to provide a clear summary of ‘what is already known on this subject?’ 
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that might identify the authors. 
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• As papers are double-blind peer reviewed, the main text file should not include any 
information that might identify the authors. Please do not mention the authors’ names or 
affiliations and always refer to any previous work in the third person. 
• The journal uses British spelling; however, authors may submit using either option, as 
spelling of accepted papers is converted during the production process. 
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References should be prepared according to the Publication Manual of the American 
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in the text, for example, (Jones, 1998). The complete reference list should appear alphabetically 
by name at the end of the paper. Please note that for journal articles, issue numbers are not 
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For more information about APA referencing style, please refer to the APA FAQ. 
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Objectives: This study aimed to identify whether a lack of social support and increased 
levels of perceived stigma predicted psychological distress for individuals with a diagnosis of 
motor neurone disease (MND) also known as amyotrophic lateral sclerosis.  Although 
identified in other neurodegenerative conditions, and in relation to quality of life for MND, 
social support and stigma have not previously been investigated as predictors of 
psychological distress in people with MND.  Design: A cross-sectional design utilising an 
online survey method was used.  It was hypothesised that both social support and stigma 
would be significant predictors of psychological distress, over and above demographic and 
clinical variables.  Methods: Individuals with a diagnosis of MND were recruited 
internationally through social media and through various organisations and support services 
for people with MND.  Seventy-seven participants completed the survey and data were 
analysed using hierarchical regression analyses.  Results: Significant correlations were 
identified between social support, felt and enacted stigma and psychological distress.  
Regression analyses revealed that enacted stigma was not an independent predictor in any of 
the models and social support did not remain a significant independent predictor for stress 
when stigma entered the model.  However, felt stigma was a significant independent 
predictor in all the models and was a more powerful predictor than social support in each of 
the models.  Conclusions: Stigma and social support may be important to consider for 
ameliorating psychological distress for people with MND.  Limitations of the current study 
are discussed, along with implications for clinical practice. 
 
Keywords: Social support; stigma; psychological distress; motor neurone disease; 
amyotrophic lateral sclerosis 






 Motor neurone disease (MND), also referred to as amyotrophic lateral sclerosis (ALS) 
and Lou Gehrig disease in the US, is a life-limiting neurodegenerative condition.  The 
condition progressively destroys the motor neurons in the brain and spinal cord and alters an 
individual’s ability to control voluntarily their muscle movements, leading to paralysis, 
swallowing difficulties, respiratory failure and ultimately, death (King, Mulligan & 
Stansfield, 2014).  The effects of MND are not limited to motor functions; behaviour 
difficulties, cognitive impairment (McCluskey et al., 2009; Strong et al., 1999) emotional 
difficulties (depression, anxiety and anger) and involuntary changes in mood (Orrell, 2016) 
are also common. 
 Characteristically, MND is more common in men than women (Stone, 1987) and the 
average age of onset is between 60 and 65 years of age, with the likelihood of developing the 
condition increasing with age (Talbot & Marsden, 2008).  The prevalence rate for North 
America and Europe is around two per 100,000 of the population (Worms, 2001) and median 
survival rates following symptom onset are generally only two to four years, with only 10%-
20% of individuals surviving past 10 years (Chiò et al., 2009). 
 Current interventions for individuals with MND mainly focus upon the physical 
aspects of the condition, to maintain physical and biological functioning and quality of life 
for as long as possible (Andersen et al., 2012).  However, a review (McLeod & Clarke, 2007) 
highlighted the lack of guidance on psychological care and the review authors proposed that, 
given a range of psychosocial issues impact on the quality of life of individuals with MND, a 
more holistic approach to care was required.  A quantitative and qualitative review, 10 years 
later, assessed literature aimed at the supportive care needs of individuals with MND and 
their caregivers.  Of the 37 studies included, 16 discussed psychological needs, 18 discussed 





social needs and 13 discussed emotional needs.  Despite more research recognising these 
needs of individuals with MND and their caregivers, the review highlighted that there is still 
a significant need for more psychological, social and emotional support, alongside physical 
and practical support (Oh & Kim, 2017).  They proposed that the psychological impact of 
receiving and adjusting to this diagnosis along with the impact of coping with the associated 
functional changes should be considered equally, in line with the physical impact of the 
condition to enhance and maintain an individual’s quality of life.  Higher levels of 
psychological well-being may also be protective for physical health as quantitative research 
suggests that individuals with a higher level of well-being may have a lower risk of mortality, 
even when disease severity and length of illness are controlled (McDonald, Wiedenfeld, 
Hillel, Carpenter & Walter, 1994).  However, even when psychological needs of low mood, 
anxiety and involuntary changes in mood are identified, management strategy literature, such 
as that produced by Gordon (2011), mainly refers to the use of medication as treatment 
options, although the use of psychotherapy was mentioned.  This indicates that psychological 
and social understandings and interventions are not always considered as the main treatment 
options when considering the psychological needs of this population.    
 Due to the challenges that the condition presents, individuals with a diagnosis of 
MND are likely to experience psychological distress and decreased well-being (Hogg, 
Goldstein & Leigh, 1994; Lou, Reeves, Benice & Sexton, 2003; Montgomery & Erikson, 
1987; Tedman, Young & Williams, 1997; Vignola et al., 2008).  Although several factors 
undoubtedly contribute to this (e.g., biological, social, psychological and spiritual suffering: 
Ganzini, Johnston & Hoffman, 1999; social withdrawal: Rigby et al., 1999 and physical 
impairment: Hunter, Robinson & Neilson, 1993; Hogg et al., 1994), recent research in other 
physical health conditions has suggested that stigma may be one important variable to 
consider.  This has been identified as important in health conditions with perceivable physical 





effects such as, epilepsy (Baker, Eccles & Caswell, 2018), Parkinson’s disease (Maffoni, 
Giardini, Pierobon, Ferrazzoli & Frazzitta, 2017) and multiple sclerosis (Cadden, Arnett, 
Tyry & Cook, 2018; Broersma, Oeseburg, Dijkstra & Wynia, 2018).    
The term stigma was originally defined by Goffman (1963) as “an undesired 
differentness” (p. 5) and this has since been developed to include two concepts of stigma; felt 
and enacted (Scambler & Hopkins, 1986).  ‘Felt stigma’ refers to a feeling of shame about 
being different and feeling that discrimination for this difference will occur, whereas ‘enacted 
stigma’ refers to actual experience of this discrimination.  This definition has since been 
developed and Link and Phelan (2001) described stigma as a set of components which 
include labelling, stereotyping, separation, status loss, and discrimination.  Therefore, the 
term stigma can encompass a range of negative actions and associations that can be attributed 
to an individual based on their differentness.    
The influence of stigma as a predictor of quality of life in individuals diagnosed with 
neuromuscular conditions including MND, has been quantitatively studied by van der Beek, 
Bos, Middel and Wynia (2013).  This study found that stigma was a major predictor of poorer 
quality of life, with ‘felt stigma’ being a stronger predictor compared with ‘enacted stigma’.  
However, this study focused on quality of life, rather than psychological distress in particular, 
and individuals diagnosed with MND only made up 9% of the total number of participants.  
Due to the life-limiting nature of MND in comparison to the other conditions included within 
the study (muscle disorder, junction disorder and peripheral nerve disorder), it seems 
important to study the effects of stigma in this population independently. 
While extensively researched in other neurodegenerative conditions such as multiple 
sclerosis (Bambara, Turner, Williams & Haselkorn, 2011; Bamer, Cetin, Johnson, Gibbons & 
Ehde, 2008; Chwastiak et al., 2002; Harrison & Stuifbergen, 2002; Suh, Weikert, Dlugonski, 





Sandroff & Motl, 2012) and Parkinson’s disease (Ghorbani Saeedian et al., 2014; Cheng et 
al., 2008), the impact of social support as a predictor of psychological distress for individuals 
with MND has only been assessed with a very small sample.  Matuz, Birbaumer, Hautzinger 
and Kübler (2010) identified perceived social support as a significant predictor of depression 
and quality of life for individuals with a diagnosis of MND which included a sample of 27 
participants.  Matuz, Birbaumer, Hautzinger and Kübler (2015) conducted a longitudinal 
study and found that social support was a significant predictor of depression and quality of 
life at a subsequent time point for this population.  However, only 27 participants were 
included at the initial time point, which reduced to 16 for the final time point.  Social support 
has also been identified as a correlate of quality of life for individuals with a diagnosis of 
MND (Ganzini, et al., 1999; Goldstein, Atkins & Leigh, 2002; Simmons, Bremer, Robbins, 
Walsh & Fischer, 2000).  However, these studies used restricted measures of social support 
which only assessed the impact of close relationships, rather than broader social support 
beyond the household (i.e. other family members or friends) and did not include a regression 
model to identify the predictive nature of social support, controlling for other variables.    
Evidence does suggest, however, that social support is an issue of concern for people 
with MND.  Mistry and Simpson (2013) conducted a qualitative study exploring the process 
of receiving a diagnosis of MND and discovered that functional changes caused by MND can 
impact on an individual’s social engagement, social status and identity, affecting an 
individual’s relationships with family and friends.  Moreover, it has also been qualitatively 
noted by Cobb and Hamera (1986) that social relationships undergo radical changes 
following a diagnosis of MND.  It therefore feels important also to quantitatively assess the 
relationship of stigma and social support on levels of psychological distress in individuals 
with MND.  Moreover, social support has already been identified as a correlate of quality of 
life and as a significant predictor of depression in this population and stigma has been 





identified as an important predictor of psychological distress in different physical health 
conditions, including neurodegenerative conditions.  Therefore, determining the role that 
each of these variables has on levels of psychological distress in people with MND, will build 
on past research and address a current gap in this area of literature.   
Consequently, this study aims to investigate the relationship between the lack of 
social support and perceived stigma on psychological distress for people with a diagnosis of 
MND.  The findings could highlight whether it is important to consider these factors when 
assessing psychological distress in practice and to inform interventions.  It also aims to 
discover the strength of these relationships when controlling for demographics and levels of 
physical functioning.  The specific research question that this study aims to answer is: Do 
lower levels of social support and increased levels of perceived stigma contribute to 
psychological distress in individuals with MND?  It is hypothesised that stigma and social 
support will each have a significant effect over and above the demographic and physical 
functioning variables in predicting psychological distress (depression, anxiety and stress) for 
individuals with a diagnosis of MND.  
Method 
Design 
 A quantitative cross-sectional survey design was used to investigate whether 
perceived stigma and social support were significant predictors of psychological distress 
(depression, anxiety and stress) in individuals with a diagnosis of MND.  The specific 
hypothesis for this study was that both perceived stigma and social support would be 
significant predictors of psychological distress in individuals with a diagnosis of MND, over 
and above demographic and clinical variables.   





The regression models were theoretically driven and based on previous research.  
Thus, the variables included in the hierarchical block regression analysis were entered as 
follows: demographics (age and gender); clinical variable (physical functioning); social 
support and stigma (felt and enacted).  Social support and stigma were entered separately to 
identify their individual relationships.  Social support was entered before stigma as this 
variable had already been identified as a predictor of depression and quality of life in 
individuals with MND, whereas stigma was a new variable to be considered as this had not 
been studied before exclusively with people with MND. 
Participants 
Individuals aged 18 years or over who had a diagnosis of MND/ ALS/ Lou Gehrig 
disease and who could complete an online survey written in English (either alone or with 
assistance from another person) were eligible to take part.  An opportunistic sampling method 
was employed as participants volunteered to participate following advertisement of the study 
details online, using social media and through international organisations.  If a participant 
wished to take part in the study, then they accessed the study link provided in the study advert 
and were given the opportunity to read and download the participant information sheet.  
Eligibility for the study was based on self-report and was recorded through a demographic 
questionnaire at the beginning of the survey.   
An a priori power calculation (using G*Power software based on 5-8 predictors, 
presuming a medium effect size of 0.15) suggested between 92 and 109 participants were 
required (80% power, alpha = .05).  A total of 77 participants were recruited; 34 females and 
43 males.  The recruitment method employed received 134 responses from participants, but 
of these, only 94 opened the survey and proceeded further.  Of those who proceeded further, 
84 completed demographic data, with only 80 of these continuing to complete the outcome 
measures.  Of the 80 who completed the outcome measures, only 78 completed all the 





measures (two participants did not complete the physical functioning measure and as such 
their data were withdrawn).  A further participant’s data were withdrawn due to not meeting 
the inclusion criteria of being completed by an individual with a diagnosis of MND, leaving a 
total of 77 participants whose data were included in the final analysis.   
Please see Table 1 for participants’ self-reported demographic characteristics.   
 
    --------------------------------------- 
Insert Table 1 here please 
    --------------------------------------- 
 
Procedure 
Ethical approval was gained from the principal investigator’s host academic 
institution (please see section 4 of the thesis for full details). 
All the study documents were reviewed by a family member of an individual who had 
a diagnosis of MND and by a service-user from the academic institution’s public involvement 
network who had an interest in this field.  The feedback gained from this consultation was 
used to decide on the measures and to review the wording of the documentation to ensure it 
was appropriate for the audience.  They also provided feedback on the duration of the study 
to ensure this would not be too burdensome for the participants.  This consultation preceded 
finalisation of the documents and submission for ethical approval as part of the research 
development process.   
Recruitment for the study took place online from a variety of sources, mainly through 
international organisations supporting people with MND.  This was achieved by sharing the 
study advert and link on social media (Facebook and Twitter) pages by the Motor Neurone 





Disease Association (MNDA) Australia, MNDA UK, MNDA New Zealand, MNDA 
Scotland, ALS Association Canada, ALS Society Quebec, Minds and Movement, Lancaster 
Centre for Ageing Research and the principal investigator.  Furthermore, the information was 
shared through newsletters, (MNDA UK and MNDA South Africa), through the research 
page of their website (MNDA UK), through staff contact with individuals with a diagnosis of 
MND (MNDA Scotland and the Les Turner Foundation – based in the USA) and through 
research databases (New Zealand MND Registry and MNDA South Africa).  The New 
Zealand MND Registry was established in 2017 to aid in the recruitment of participants for 
research projects and in July 2018 they had 142 participants enrolled on their database 
expressing an interest in participating in research (Walker et al., 2019), therefore they were 
able to provide a useful contribution to the recruitment process.   
An online survey was constructed using Qualtrics software which was used to collect 
the data.  Prior to the commencement of the survey each participant was shown the 
participant information sheet and had the chance to download this for their own reference.  
Participants had to complete the consent form prior to being allowed to start the survey.  
Following completion of each of the questionnaires, a debrief sheet was shown to each 
participant and they had the opportunity to download this for their own reference.  Both the 
participant information sheet (see appendix 4-B of ethics section) and debrief sheet (see 
appendix 4-D of ethics section) informed participants that the information provided was 
anonymous, meaning that no personal identifiable information was held and therefore it was 
not possible to withdraw data once the survey had begun as an individual’s data could not be 
identified.  The personal details of any participants who requested to access a copy of the 
results were held long enough to send out this information, then were destroyed and this 
information was kept confidential throughout the process.  Both the participant information 





sheet and debrief sheet provided the contact details of organisations who could provide 
support if participation in the study caused any distress for individuals.   
 Measures   
 To control for potential confounders, measures were included to assess demographic 
variables (age and gender) and a clinical variable (physical functioning), along with the two 
variables of interest (social support and stigma).  One measure was used to assess the 
outcome of psychological distress (measuring stress, anxiety and depression).    
 To situate the sample additional variables were collected including nationality, 
relationship status, time since symptom onset and time since diagnosis. 
Demographic and Clinical data 
The survey included a self-report questionnaire requesting the participants’ 
demographic characteristics (age, gender, nationality and relationship status) and some 
clinical characteristics (time since symptom onset and time since diagnosis).  The following 
were also administered: 
Physical Functioning 
The Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale 
Revised (SA-ALSFRS-R; Cedarbaum et al., 1999; Montes et al., 2006) includes 12 questions 
which assess the domains of motor function, bulbar symptoms and breathing ability in 
individuals with MND.  A scoring sheet is provided to score individual item responses on a 
scale of 0 to 4 with a total score range of 0 to 48, with higher scores indicating higher levels 
of physical functioning.  Although there is no current evidence regarding the reliability and 
validity of the SA-ALSFRS-R, there is evidence regarding the clinician administered 
ALSFRS-R.  This has been shown to be a reliable and valid measure by the authors during 





development (Cedarbaum et al., 1999).  Internal reliability was displayed by Cronbach’s 
coefficient alpha score of 0.73 for the total scale.  Montes et al. (2006) compared the use of 
the SA-ALSFRS-R to the clinician administered ALSFRS-R and reported an intraclass 
correlation coefficient score of r = 0.93, implying that the self-administered version is as 
reliable as the clinician administered version.  This measure was chosen as it is aimed 
specifically at individuals with a diagnosis of MND to assess their physical functioning and 
symptom severity.   
The use of the ALSFRS-R instrument online compared to on-site face-to-face 
assessment was assessed by Maier et al. (2012) and their results supported the use of the 
measure online, due to a highly significant correlation between on-site evaluation and online 
testing (r = 0.96).   The SA-ALSFRS-R was developed specifically for use with individuals 
with a diagnosis of MND and is therefore suitable for use with this population.   
Social Support  
The Multidimensional Scale of Perceived Social Support (MSPSS; Zimet, Dahlem, 
Zimet & Farley, 1988) is a 12-item measure scored on a scale from 1 (very strongly disagree) 
to 7 (very strongly agree) with a total score range of 12 to 84 with four questions for each of 
the three subscales: significant other, family and friends (scores range from 4 to 28 for each 
subscale).  Scores can be used for the total scale and for the subscales, with higher scores 
indicating higher levels of social support.  This is a valid and reliable measure as reported by 
the authors.  Cronbach’s coefficient alpha scores are given as 0.91 for the significant other 
subscale, 0.87 for the family subscale, 0.85 for the friends subscale and 0.88 for the total 
scale.  Test-retest reliability for each of the significant other, family, and friends subscales 
was 0.72, 0.85, and 0.75 respectively and the total scale was 0.85.  This was chosen to assess 
social support because this is a relatively short and easy to complete measure, reducing 





participant burden.  It is a measure which provides an insight into an individual’s levels of 
social support from different sources, providing subscales for these in relation to family, 
friends and significant others.   
To the best of the authors knowledge, this measure has not previously been used 
online, nor with people with MND, however, it has been used with individuals with multiple 
sclerosis (Hyarat, Al-Gamal & Rama, 2018; Koelmel, Hughes, Alschuler & Ehde, 2017).   
Stigma 
The Stigma Scale for Chronic Illness (SSCI, Rao et al., 2009) comprises 24 questions 
with two subscales; one scale for felt stigma (labelled self-stigma) and one scale for enacted 
stigma.  There are 13 questions for the felt stigma scale which relate to an individual’s fear of 
discrimination and 11 questions for the enacted stigma scale which includes questions 
relating to their actual experience of discrimination in relation to illness.  Each item is scored 
on a scale of 0 (never) to 4 (always) with a total score range of 0 – 96 for the full scale, 
between 0 – 52 for the felt scale and between 11 – 44 for the enacted scale.  Higher scores 
indicate a higher level of stigmatisation.  Internal reliability for this scale was assessed by the 
authors during development, and it was found to be a reliable measure with promising 
psychometric properties (Cronbach’s coefficient alpha was 0.97 for the full-scale, with both 
subscales correlating strongly r = 0.81).  This measure has been used in this study to assess 
levels of perceived stigma and was chosen because it has been specifically developed for 
people with chronic neurological illnesses, including individuals with MND.  The total score 
was used alongside the two subscales (felt and enacted stigma) for the correlational analyses 
for this study and the two subscales were used in the regression analyses of this study. 
The authors of this measure used it online during the validation on the psychometric 
properties of the measure (Rao et al., 2009) indicating its feasibility for online use.  During 





validation of the measure, participants with a diagnosis of MND were included, providing 
evidence for its use with this population.   
Psychological Distress 
The Depression, Anxiety and Stress Scale (DASS-21; Lovibond & Lovibond, 1995) 
has 21 questions scored across three subscales, depression, anxiety and stress, with seven 
questions for each subscale.  These are scored on a range of 0 (never) to 3 (almost always) 
with a total range of 0 – 21 for each of the subscales.  Higher scores indicate a higher level of 
distress and scores can be categorised as: “normal”, “mild”, “moderate”, “severe” or 
“extremely severe” ranges.  This has been found to be an internally reliable measure, with 
Cronbach’s coefficient alphas of 0.94 and 0.88 reported for the depression subscale, 0.87 and 
0.82 for the anxiety subscale and 0.91 and 0.90 for the stress subscale (Antony, Bieling, Cox, 
Enns, Swinson and Haynes, 1998; Henry and Crawford, 2005).  This was selected to assess 
levels of psychological distress because it captures three forms of psychological distress 
within one measure, but with three subscales, it is non-combinable and relatively short to 
complete.   
This measure has been used online in previous research with a sample of community-
based carers (Farrugia, Hewitt, Bourke-Taylor & Joosten, 2019).  This measure has been used 
to measure psychological distress in other research in individuals with MND (Lillo, Mioshi, 
Zoing, Kiernan & Hodges, 2011; Caga, Ramsey, Hogden, Mioshi & Kiernan, 2015) as well 
as individuals with Parkinson’s disease (Troeung, Egan & Gasson, 2014; Whitworth et al., 
2013).    
Data Analysis 
 Data analysis was completed using SPSS Version 25.  The sample was checked for 
missing data prior to any analysis being conducted, and seven participants had not provided a 





response to the same question on the SSCI: “people with my illness lost their jobs when their 
employers found out”.  This missing datum was appropriately replaced with a mean value of 
2 based on the mean of the specific subscale of the SSCI (enacted subscale).  No other 
missing data was identified in the sample.  Outliers were identified using boxplots and scores 
were checked for errors.  The only outliers identified were for variables which were not 
included in the final analyses therefore no further action was required.  All data were first 
checked for normality by using the Kolmogorov-Smirnov test, which yielded significant 
results, so a less conservative method of dividing the skewness or kurtosis value by its 
standard error was used due to the small sample size (Field, 2005).  Using parameters of -3 to 
+3 the only scale not normally distributed for skewness and kurtosis was the MSPSS total 
score.   
As the MSPSS total score was not normally distributed, non-parametric correlations 
were calculated using Spearman’s correlation coefficients to identify relationships between 
the variables.  Then a theoretically driven hierarchical block regression was conducted and 
entry into regression was based on theoretical grounds.  The predictors were entered in a 
stepwise manner, in four blocks, based on their importance as identified from previous 
research: 1) demographics (age and gender), 2) clinical variable (physical functioning) 3) 
social support and 4) stigma (felt and enacted).  Three regression models were conducted – 
one for each of the three outcome variables: stress, anxiety and depression.   
 The Durbin-Watson statistic was checked for each of the models to determine whether 
the assumption of the independent errors was tenable, and all these values fell within the 
limits of +1 to +3.  Variance inflation factors (VIF) were also checked and all of these were 
below 10, with the average VIF values being near the one mark (range = 1.009 – 1.945).  
Different rules of thumb have been advocated for VIFs (e.g., <10 or <4: see O’Brien, 2007) 
but with the average VIF value for these analyses being 1.195, multicollinearity was not a 





concern.   The assumptions of the model were also checked by assessing the scatterplot of the 
standardised residuals against the standardised predicted values, the histogram of 
standardised residuals and the normal probability plots.  These showed that the assumptions 
of linearity and homoscedasticity were met and that the standardised residuals were normally 
distributed.  All standardised residuals fell within -3.29 to +3.29 suggesting there were no 
outliers and the model fitted the data (Field, 2013).  
Results 
Participants 
 The demographic and clinical characteristics of these participants can be viewed in 
Table 1.  More participants were male (n = 43) and the mean age of the sample was 59 years.  
The most common nationality reported by participants was ‘New Zealander’ (n = 18) and 
most participants were married (n = 55).  Time since symptom onset had a median duration 
of 3.5 years (mean 4.75 years) and time since diagnosis had a median duration of 2.4 years 
(mean 3.53 years).  Most participants did not require carer assistance to complete the survey 
(n = 70).   
 The mean scores, standard deviations and Cronbach’s alpha scores for each measure 
are reported in Table 2.   
 
--------------------------------------- 
Insert Table 2 here please 
--------------------------------------- 
 
The mean (SD) score for the SA-ALSFRS-R was 29 (8.62), indicating that levels of 
independent functioning were within the mid-point range (minimum score is 0 and maximum 
score is 48, with higher scores indicating higher levels of independent functioning).  The 





majority of scores fell within the ‘mild to moderate’ category (43%, n = 33), the next 
common category was ‘moderate to severe’ (30%, n = 23), followed by the ‘advanced 
disease’ category (16%, n = 12) and finally the ‘minimal to mild’ category (12%, n = 9).   
The mean (SD) score for the MSPSS total was 66.47 (15.66), indicating that levels of 
social support were towards the higher end of the scale for this sample (minimum score is 12 
and maximum score is 84, with higher scores indicating higher levels of social support).  The 
mean (SD) score for the SSCI total score was 32.83 (16.12), indicating that levels of stigma 
were quite low in this sample (minimum score is 0 and maximum score is 96, with higher 
scores indicating higher levels of stigma).  For the SSCI self-subscale (measuring self-
stigma) the mean (SD) score was 22.48 (10.36), and for the SSCI enacted-subscale the mean 
(SD) score was 10.09 (7.09).   
The mean (SD) scores for the outcome variables (stress, anxiety and depression) were 
7.03 (4.59), 5.32 (3.85) and 7.19 (5.21) respectively.  For the stress subscale, the majority of 
scores were in the ‘normal’ category (62%, n = 48), the next most common category was 
‘moderate’ (22%, n = 17), followed by the ‘mild’ category (9%, n = 7), followed by the 
‘severe’ category (5%, n = 4) and finally the ‘extremely severe’ category (1% n = 1).  For the 
anxiety subscale, all the scores fell within the ‘normal’ category (100%, n = 77).  For the 
depression subscale, the majority of scores were in the ‘normal’ category (70%, n = 54), the 
next most common category was ‘mild’ (18%, n = 14), followed by the ‘moderate’ category 
(12%, n = 9).  This indicates that the majority of the sample had ‘normal’ levels of stress, 
anxiety and depression.   
Correlations 
 Spearman’s rho correlation coefficients were calculated to determine the relationships 
between the variables; see Table 3 for the results of these correlations.    
 







Insert Table 3 here please 
    --------------------------------------- 
 
None of the demographic variables or the clinical variable correlated significantly 
with the outcome variables of stress, anxiety and depression.  Statistically significant 
relationships were found between the main predictors of stigma and social support and all 
three outcome variables.   
Social support (total score) was negatively correlated with all the DASS-21 scales 
(stress: rₛ = -0.385, p = 0.01; anxiety: rₛ = -0.399, p = 0.01; depression: rₛ = -0.437, p = 0.01) 
indicating that less social support is associated with higher levels of stress, anxiety and 
depression.  The social support total score was also negatively correlated with the stigma total 
score (rₛ = -0.483, p = 0.001).   
Stigma (total score) was positively correlated with all the DASS-21 scales (stress: rₛ = 
0.538, p = 0.01; anxiety: rₛ = 0.447, p = 0.01; depression: rₛ = 0.660, p = 0.01).  The stigma 
self-subscale (measuring felt stigma) was also positively correlated with all the DASS-21 
scales (stress: rₛ = 0.525, p = 0.01; anxiety: rₛ = 0.526, p = 0.01; depression: rₛ = 0.689, p = 
0.01).  The stigma enacted-subscale was also positively correlated with all the DASS-21 
scales (stress: rₛ = 0.440, p = 0.01; anxiety: rₛ = 0.244, p = 0.05; depression: rₛ = 0.465, p = 
0.01), indicating that higher levels of stigma are associated with higher levels of stress, 
anxiety and depression, with self (felt) stigma having a stronger correlation than enacted.   
Regression 
 Hierarchical block regression models were conducted; see Tables 4 to 6 for the results 
of this analysis.   

















Insert Table 6 here please 
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Regression model predicting stress. 
Demographic and clinical variables made up less than 5% of the variance at 
predicting the DASS-21 stress scores, whereas, social support added a further 15% of the 
variance, which was increased by a further 25% of variance to a total of 45% variance (41% 
adjusted R² variance) when the stigma self-subscale and enacted-subscale were added to the 
model.  The overall model at step four was significant (F = 9.671, p = < 0.001).   
Social support was identified as a statistically significant predictor for stress at step 
three of the model (β = -.408, p = < 0.001), however this was no longer statistically 
significant when stigma (self-subscale and enacted-subscale) entered the model at step four.  





At step four only the self-subscale of stigma was a significant independent predictor of stress 
(β = .434, p = < 0.001). 
Regression model predicting anxiety. 
For the DASS-21 anxiety scores, a different pattern emerged.  Demographic and 
clinical variables accounted for less than 5% of the variance, social support added a further 
17% of the variance, and the stigma self-subscale and enacted-subscale added a further 15% 
of variance for a model total of 37% of the variance (31% adjusted R² variance).  The final 
model was significant (F = 6.709, p < = 0.001).   
Social support was identified as a significant predictor for anxiety at step three of the 
model (β = -.434, p < 0.001).  It remained a significant independent predictor at step four (β = 
-.260, p < 0.05), alongside self-stigma (β = .485, p < 0.001). 
Regression model predicting depression. 
The model predicting the greatest variance was for the DASS-21 depression scores.  
Demographics and clinical variables accounted for less than 4% of the variance, social 
support added a further 22% of variance and stigma total score added a further 30% of 
variance, resulting in a total model variance of 56% (52% adjusted R² variance).  The final 
model was significant (F = 14.917, p < 0.001).   
Social support was identified as a statistically significant predictor of depression at 
step three of the model (β = -.490, p < 0.001).  It just remained a significant independent 
predictor at step four (β = -.192, p < 0.05), alongside the self-subscale of the stigma measure 
(β = .603, p < 0.001).    
Discussion 
The present study investigated the impact of social support and perceived stigma in 
contributing to psychological distress in individuals with MND.  Statistically significant 
correlations were found between social support, stigma (total score, self-subscale and 





enacted-subscale) and all the outcome variables, highlighting the significance of these 
relationships.  Hierarchical regression analyses revealed that enacted stigma was not an 
independent predictor in any of the models and social support did not remain a significant 
independent predictor for stress when stigma entered the model.  Moreover, felt stigma was a 
more powerful predictor than social support in each of the models. 
This study is the first, to the best of the authors knowledge, to investigate social 
support as a predictor of psychological distress (conceptualised as stress, anxiety and 
depression) in individuals with a diagnosis of MND controlling for demographics and 
physical functioning.  The results of this study suggest that individuals with higher levels of 
perceived social support have lower levels of psychological distress.  This indicates that 
having access to adequate social support can be a protective factor for avoiding psychological 
distress for individuals with a diagnosis of MND.  These findings are consistent with one of 
the most dominant theories in social support research; the stress buffering model (Barrera, 
1986; Cohen & Wills, 1985; Cutrona & Russell, 1990; Thoits, 1986) which is an extension of 
the Lazarus (1966) and Lazarus and Folkman’s (1984) general stress and coping theory 
(Lakey & Orehek, 2011).  Applied in the context of this study, this theory suggests that social 
support would act as a buffer between MND related stress and psychological distress and thus 
reduce distress. 
By having adequate support from friends, family and significant others with regards 
to emotional and practical matters, some of the difficulties that individuals with MND 
experience could be improved.  These difficulties include having to develop and adjust their 
adaptation strategies as the condition progresses, as well as functional changes which can 
impact the individual’s ability to complete tasks or engage socially due to experiences of 
changing identity, social status and social relationships (Mistry & Simpson, 2013).  Having 





high levels of support in place to help manage these transitions and experiences can be 
beneficial to the individual’s levels of psychological distress.   
Turning to stigma, previous research had identified stigma as a significant predictor of 
quality of life in individuals with a diagnosis of MND (van der Beek et al., 2013), however 
this study did not use an exclusively MND sample, and the focus was on quality of life, rather 
than psychological distress.  Therefore, this research is the first, to the best of the author’s 
knowledge, to identify the predictive nature of stigma for psychological distress, in a sample 
which was exclusively individuals with a diagnosis of MND.   
The correlational findings indicate that individuals with higher levels of stigma (both 
felt and enacted) have higher levels of psychological distress.  However, in the regression 
analyses, only the self-subscale (measuring felt stigma) was a significant independent 
predictor of psychological distress.  These results partially support the findings by van der 
Beek et al., (2013) who found that both the enacted-subscale and self-subscale components 
were independent significant predictors of quality of life.  However, the self-subscale was 
identified as a stronger independent predictor than the enacted-subscale component.  This 
suggests that felt or internalised beliefs about being stigmatised are more influential on 
psychological distress than actual experiences of discrimination (enacted).  Felt stigma was a 
stronger predictor than enacted stigma and came out independently when predicting the 
variance for each of the models.  Interestingly, Scambler and Hopkins (1986) found that 90% 
of their participants with a diagnosis of epilepsy had experienced felt stigma, whereas only a 
third of these had experienced enacted stigma.  They suggested that this discrepancy between 
levels of felt and enacted stigma may be attributed to the public being more informed and 
tolerant of the condition, than expected by academics and individuals with epilepsy.  This 
was also theorised by Furnham and Lane (1984) with regards to individuals experiencing 
deafness. 





 Strengths and Limitations  
The majority of participants were male (55.8%), meaning this sample differed from 
more specific estimates of prevalence rates which suggest that MND is 54% higher in males 
than females (Alonso, Logroscino, Jick & Hernán, 2009).  The mean age of this sample was 
59 years, which is younger than the average age of onset of between 60 and 65 years 
identified in past research (Talbot & Marsden, 2008).   The mean time since symptom onset 
for this sample was 4.75 years (median 3.5 years), which can be considered a long duration, 
as the median survival rate following symptom onset has been reported as between 2 to 4 
years (Chiò et al., 2009).  Therefore, the time since symptom onset for this sample was longer 
than would be expected.  Moreover, 10% of the participants in this sample had a symptom 
duration time that exceeded 10 years, in line with the figures suggested by Chiò et al., 2009 
which suggests that 10-20% of individuals survive past 10 years following symptom onset.  
However, as this study was conducted online, this may bias the sample towards younger 
people.  Also, most participants in this study (55%) had higher levels of physical functioning, 
indicating that they were able to function independently despite the symptom durations 
reported.  This higher rate of physical functioning may relate to the online nature of the study 
design, in that those who chose to participate in the study were those who had more ability to 
access it.   
This study used a cross-sectional design which has known limitations such as the 
difficulty in making causal inferences and only gathering data at a single time-point (Levin, 
2006).  The results suggest that having high levels of stigma correlate with high levels of 
depression, however the direction of this relationship cannot be assumed.  It is possible that 
this is a bi-directional relationship and that having high levels of depression could cause high 
levels of felt stigma as an individual may be more susceptible to internalising negative 
perceptions about their condition.  Previous research has identified a bi-directional 





relationship between stigma and depression in a sample of children affected by HIV/ AIDS, 
whereby higher levels of depression predicted higher levels of perceived stigma which then 
predicted higher levels of enacted stigma.  This suggested a vicious cycle as higher levels of 
enacted stigma also directly predicted subsequent higher levels of depression (Chi, Li, Zhao 
& Zhao, 2014).  Therefore, understanding whether a similar relationship exits for individuals 
with MND would be beneficial.  Alternatively, it could be that high levels of felt stigma 
cause higher levels of depression due to negative consequences of feeling stigmatised.  In 
order to improve this and allow causal inferences to be made, longitudinal studies need to be 
conducted, using more complex statistical models such as regressions that predict the 
outcomes at subsequent timepoints.  Using statistical models that unpack the mechanisms of 
these relationships, such as identifying mediating and moderating effects would also add to 
our understanding.    
Sample size is a limitation in this study, as only a relatively small sample size was 
achieved, however, challenges were encountered trying to access this population due to the 
relative rarity of the condition.  An a priori power calculation had been conducted prior to 
recruitment commencing, which estimated that a minimum of 92 participants would be 
required to detect a medium effect size (0.15) with 80% power, and 5-8 predictors.  However, 
the final models (with 6 predictors) actually found large effects (explaining 30-52% of the 
variance in the outcomes) and post-hoc calculations suggest the power achieved was over 
99% for the whole models.  Nonetheless, social support may have remained a significant 
predictor in the stress model if a larger sample size had been achieved.   
Another issue that was encountered during this study was the recruitment of 
participants.  Due to the low prevalence rates of MND, an online survey method was used to 
recruit participants internationally.  This was a successful method to increase participant 
numbers, however, this relied on organisations and support services in individual countries to 





advertise and share the study information in order to recruit participants and certain countries 
such as the USA were hard to reach in this respect.  Only one local organisation (The Les 
Turner Foundation) in the USA shared this information, resulting in only a small proportion 
(3%) of participants from this country.  Nonetheless this method of recruitment was 
successful in various other countries and a sufficient sample size was gained.   
A further limitation to the study was that participants were only recruited if they were 
able to understand English well enough to complete the study measures, so the results may 
not be generalisable across cultures and ethnicities.  Only nationality, not ethnicity, was 
recorded as part of the demographic questionnaire and the majority of these (87%) reported 
an English-speaking nationality.  Also, participants were accessed online, biasing the sample 
towards those who had the means and ability to access the internet.  This could result in some 
populations without internet access being underrepresented or neglected from the current 
sample.   
Furthermore, the levels of stigma were quite low in this sample, and most of the 
sample had ‘normal’ levels of stress, anxiety and depression.  A review of psychosocial 
aspects of MND (McLeod & Clarke 2007) identified varying prevalence rates of depression 
and anxiety within MND populations, these ranged from 0% to 50% for depression (defined 
as moderate to severe) and 11% to 26% for anxiety.  Therefore, given the high variability, it 
is unclear whether the current sample may be considered representative.  However, the 
present findings may not be applicable to samples with higher levels of stigma and 
psychological distress.       
 Clinical Implications 
 The findings from this study provide implications for clinical practice, as they 
highlight the importance of perceived social support and stigma in predicting psychological 
distress for individuals with a diagnosis of MND.  This suggests that if psychological distress 





is identified in an individual with MND, then it may be beneficial to use social and 
psychological understandings and interventions aimed at reducing felt stigma and enhancing 
social support.   
Interventions aimed at targeting stigma often operate on several levels; intrapersonal, 
interpersonal, organisational/ institutional, community and governmental/ structural 
(Heijnders & Van Der Meij, 2006).  Systematic reviews have identified that the most 
effective interventions are aimed at the intrapersonal, interpersonal and community levels 
(Heijnders & Van Der Meij, 2006; Rao et al., 2019).  Effective intervention strategies for 
reducing stigma for conditions such as HIV, mental health diagnoses and leprosy include 
education (Arole, Premkumar, Arole & Maury, 2002; Brown, 2009; Ngoc, Weiss & Trung, 
2016; Patalay et al.,2017), counselling (Jürgensen, Sandøy, Michelo & Fylkesnes, 2013; 
Lusli et al., 2016) , cognitive behavioural therapy (Corrigan & Calabrese, 2005, Hall & 
Tarrier, 2003) social marketing (Henderson et al., 2012), drama therapy (Orkibi, Bar & 
Eliakim, 2014) and social support groups (Demissie, Getahun & Lindtjørn, 2003; Lyon & 
Woodward, 2003; Thurman, Jarabi & Rice, 2012) along with combinations of these different 
approaches (contact, counselling and education: Uys et al., 2009; education, contact and 
social marketing: Pinfold, Thornicroft, Huxley & Farmer, 2005; social support and 
counselling: Fawzi et al., 2012).  Moreover, research suggests that mindfulness is positively 
associated with stigma resistance in individuals with a psychiatric diagnosis (Chan, Lee & 
Mak, 2018) suggesting that mindfulness-based interventions may be beneficial in reducing 
stigma.  Mindfulness-based interventions have also been identified as effective in reducing 
psychological distress for individuals with a diagnosis of MND (Pagnini et al., 2015; Pagnini 
et al., 2017).   
 The concept of psycho-emotional disablism (Simpson & Thomas, 2014) is a useful 
conceptual framework for understanding how society can impose limitations and barriers to 





an individual, making it appear that they lack these abilities.  The term ‘disablism’ was 
defined by Thomas (2007) as “a form of social oppression involving the social imposition of 
restrictions of activity on people with impairments and the socially engendered undermining 
of their psycho-emotional wellbeing” (p.73).  By taking this approach towards an individual’s 
levels of impairment, as opposed to a pathologising, individualising approach, clinical 
psychologists can aim to effect societal change to combat stigma by advocating for the 
individuals they work with, with the aim of working towards the individuals ‘real world’ 
goals and objectives.  This framework aims to effect change at a community/ structural level 
and when used in combination with the above intrapersonal, interpersonal and community 
interventions could begin address the negative influence that stigma can have on the 
psychological well-being of individuals with a diagnosis of MND.  
Social support interventions may also be beneficial to reduce psychological distress, 
however there is a lack of evidence regarding their effectiveness, particularly for individuals 
with MND.  A meta-analysis conducted by Pfeiffer, Heisler, Piette, Rogers and Valenstein 
(2011) found that social support interventions, such as peer support, have been found to help 
reduce levels of depression in mixed samples of individuals, however, this did not include a 
specific MND sample.  Therefore, more research is needed investigating social interventions 
which may increase social support and decrease stigma.  This can help develop the area of 
psychological support for the management of psychological distress on offer to individuals 
with a diagnosis of MND, which has been previously identified as an area in need of 
development (McLeod & Clarke, 2007; Oh & Kim, 2017).   
Future Research 
 As social support and stigma both significantly predict psychological distress in 
individuals with MND it may be advantageous to explore the relationship between these 
variables further.  The stress buffering model (Barrera, 1986; Cohen & Wills, 1985; Cutrona 





& Russell, 1990; Thoits, 1986) suggests that social support acts as a buffer between MND 
related stress and psychological distress.  Therefore, research to assess whether social support 
acts as a buffer between stigma (or other MND-related stressors) and psychological distress 
would be beneficial to determine the relationship between these variables.  The data collected 
from this research could be reanalysed to test the stress buffering hypothesis.   
 Furthermore, research using more complex models to identify the direction of the 
relationship between stigma and depression for individuals with MND could be beneficial, as 
there is a lack of evidence in this area, yet previous research has identified this in other 
populations such as children affected by HIV/AIDS (Chi et al., 2014).   
Conclusion 
 The findings of the present study indicate that social support and stigma are both 
significantly correlated with psychological distress in individuals with a diagnosis of MND.  
Regression analyses revealed that enacted stigma was not an independent predictor in any of 
the models and social support did not remain a significant independent predictor for stress 
when stigma entered the model.  Moreover, felt stigma was a significant independent 
predictor in all the models and was a more powerful predictor than social support in each of 
the models.  These findings can have a beneficial impact upon individuals with a diagnosis of 
MND as they highlight the importance of considering social and psychological factors when 
psychological distress has been identified.  This can then inform management strategies and 
psycho-social interventions to help reduce the levels of psychological distress experienced by 
this population.  Further research investigating the relationship between the variables of 
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Table 2: Descriptive statistics for all study measures 
Variable Mean Standard Deviation Cronbach’s alpha 
DASS-21 Stress 7.03 4.59 .86 
DASS-21 Anxiety 5.32 3.85 .75 
DASS-21 Depression 7.19 5.22 .91 
SA-ALSFRS-R 29.00 8.62 .82 
MSPSS Total 66.47 15.66 .94 
MSPSS Significant Other 24.10 5.68 .94 
MSPSS Family 22.16 6.16 .90 
MSPSS Friends 20.21 6.27 .91 
SSCI Total 32.83 16.12 .92 
SSCI Self-Subscale 22.48 10.36 .90 
SSCI Enacted-Subscale 10.09 7.09 .87 
Note: DASS-21 = Depression, Anxiety and Stress Scale; SA-ALSFRS-R = Self-Administered 
Amyotrophic Lateral Sclerosis Functional Rating Scale Revised; MSPSS = Multidimensional Scale 
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Table 3: Correlation matrix for variables displaying Spearman’s correlation coefficients  
Variable Age Gender SA-ALSFRS-R MSPSS 
Total 








Age 1.000 .090 -.031 .198 -.134 -.140 -.179 -.175 -.026 -.052 
Gender  1.000 -.165 -.097 .028 .014 -.016 .114 -.067 -.070 
SA-ALSFRS-R   1.000 .255* -.402** -.395** -.232* -.153 -.209 -.180 
MSPSS Total    1.000 -.483** -.483** -.433** -.385** -.399** -.437** 
SSCI Total     1.000 .929** .801** .538** .447** .660** 
SSCI Self      1.000 .586** .525** .526** .689** 
SSCI Enacted       1.000 .440** .244* .465** 
DASS-21 Stress        1.000 .627** .787** 
DASS-21 
Anxiety 
        1.000 .588** 
DASS-21 
Depression 
         1.000 
* p < 0.05; ** p < 0.01 
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Table 4: Summary of hierarchical multiple regression analysis model for DASS-21 Stress 
 Standardised 
Beta Coefficient 














































.453** .406** .250** 9.671** 















Table 5: Summary of hierarchical multiple regression analysis model for DASS-21 Anxiety 
 Standardised 
Beta Coefficient 














































.365** .311** .145** 6.709** 
















Table 6: Summary of hierarchical multiple regression analysis model for DASS-21 Depression 
 Standardised 
Beta Coefficient 














































.561** .524** .299** 14.917** 
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This section of the thesis aims to provide a critical appraisal of aspects of the whole 
thesis.  Firstly, I will provide an overview of the findings from the systematic literature 
review and empirical research paper.  I will discuss the similarities and differences between 
multiple sclerosis (MS) and motor neurone disease (MND) and the relevance of these in 
relation to social support and stigma.  I will then discuss the issues which I encountered 
during the recruitment process for the empirical paper and the conceptual framework of 
disability used to guide the terminology applied to both papers.  I will then discuss some 
personal reflections on why I chose this research topic and what I learned from this process.  
Finally, I will make recommendations for future research. 
Main Findings 
Systematic Literature Review 
 The review focused on psychological correlates of social support for individuals with 
a diagnosis of MS.  The definition for a psychological variable adopted for the systematic 
review was “potentially modifiable factors relating to the individual’s attitudes, thoughts, 
feelings, and behaviours that would be relevant and possible to address in a psychological 
intervention” (Dennison, Ross-Morris & Chalder, 2009, p.142).   
A systematic review identified 21 studies that assessed the relationship between social 
support and psychological variables which met the above definition.  The psychological 
variables assessed in the 21 studies were anger, anxiety, coping, depression, hope, loneliness, 
mental aspects of health-related quality of life, mental health status, post-partum emotional 
distress and psychological adjustment.  The studies included in the review reported 
correlational and regression analyses and all the studies theorised social support as a predictor 
in their research.   





Statistically significant correlations were identified for all the above psychological 
variables apart from coping.  Higher levels of social support were correlated with lower 
levels of anger, anxiety, depression, loneliness and psychological adjustment.  Higher levels 
of social support were also correlated with higher levels of hope, mental aspects of health-
related quality of life, mental health status, postpartum emotional distress and self-esteem.   
In regressions, greater social support was also shown to be a statistically significant 
predictor of less anxiety, anger, depression and loneliness.  Furthermore, greater social 
support was also found to be a significant predictor of better mental aspects of health-related 
quality of life, postpartum emotional distress and self-esteem. The correlations with the 
largest effect size were between social support and depression and mental composite of 
quality of life.  The variable with the largest number of studies and significant results was 
depression, followed by mental aspects of health-related quality of life.  Mental aspects of 
health-related quality of life and depression also had some of the highest quality assessment 
ratings, strengthening these findings. 
Empirical Research Paper 
The empirical research paper aimed to answer the research question: does a lack of 
social support and perceived stigma contribute to psychological distress in individuals with 
motor neurone disease (MND)?  Seventy-seven participants were recruited through various 
international organisations supporting individuals with MND (see Appendix 3-1 for list of 
organisations who shared the study details) and through social media.  Participants were 
required to complete an online survey consisting of the study measures.  To control for 
potential confounders, measures were included to assess demographic variables and physical 
functioning, along with the two variables of interest (social support and stigma).  Finally, one 





measure was used to assess the outcome of psychological distress (measuring stress, anxiety 
and depression).   
Statistically significant relationships were found between the main predictors of 
stigma and social support and all three outcome variables.  Higher levels of stigma were 
correlated with higher levels of stress, anxiety and depression and higher levels of social 
support were correlated with lower levels of stress, anxiety and depression.   
Greater social support was identified as a statistically significant predictor for lower 
stress, anxiety and depression, when controlling for demographics and physical functioning 
and remained significant when stigma entered the model, for anxiety and depression, but not 
for stress.   Greater felt stigma was identified as a statistically significant predictor for higher 
levels of stress, anxiety and depression and all the final models were significant.  Therefore, 
stigma and social support may be important considerations for ameliorating psychological 
distress in people with MND. 
The Relationship Between MS, MND, Social Support and Stigma 
 MS and MND are both neurodegenerative conditions, eliciting neurological 
symptoms in the individual which progressively worsen over time (Chaudhuri, 2013; Gordon, 
2011).  There are also similarities in terms of the types of symptoms that individuals 
experience as both conditions affect muscle movement and mobility, damage the brain and 
spinal cord and cause scarring or hardening around nerve cells (Amor & van Noort, 2012; 
Leigh et al., 2003; Howard & Orrell, 2002; Brown & Al-Chalabi, 2017).  However, there are 
substantial differences between the conditions, mainly with regards to the course of 
progression and outcome.  MS is not classified as a life-limiting illness, as life expectancy is 
only shortened by a few months (Rolak, 2003), however, this can increase to a shortened life 
expectancy of 5-10 years for 30% of individuals with relapsing-remitting MS (Raffel, 
Wakerley & Nicholas, 2016).  In contrast to this, MND is considered a life-limiting illness 





and median survival times following symptom onset are generally two to four years, with 
only 10%-20% of individuals surviving past 10 years (Chiò et al., 2009).  Furthermore, the 
progression of functional impairment also differs between the two conditions.  In MND the 
progression of functional impairment is typically rapid and relentless (Brown & Al-Chalabi, 
2017); conversely, MS initially presents with a relapsing-remitting presentation of functional 
impairment in 90% of cases (Raffel et al., 2016).  This relapsing-remitting presentation is 
highly variable and symptoms can fluctuate significantly (Rolak, 2003).  Although this is not 
present in all cases, the progressive nature of other forms of MS - primary-progressive; 
secondary-progressive; and progressive-relapsing - occur over a much longer time period 
than that of MND (Lorscheider et al., 2016; Rocca et al., 2017; Salemi et al., 2013).   
 These differences are relevant when conducting research on social support and 
stigma.  As the progression of the condition in MS typically fluctuates in the initial stages, it 
would be expected that the need for social support would also fluctuate.  Research 
investigating the role of social support in MS have found that individuals with MS recruit 
more social support when their levels of impairment are higher (Rommer, König & Zettl, 
2016) but that they perceive less social support when their functional impairment is higher 
(O’Brien, 1993), i.e. despite the higher level they do not feel it meets their needs at that time.  
It could also be hypothesised that individuals with MS would have higher levels of overall 
social support than those with MND, as when the symptoms of MS are in remission, then 
access to social relationships and opportunities to socialise are more available.  Conversely, 
for individuals with MND the functional impairment presents a persistent and rapid decline, 
suggesting that their access to social support and relationships would decrease as their 
condition progressed.  Moreover, research has identified that individuals with MND 
experience higher levels of stigma than those with MS (Molina, Choi, Cella & Rao, 2013).  
Further research has also identified that for individuals with MND, stigma is a significant 





predictor of social withdrawal which may partially mediate the effects of functional 
impairment (Schlüter, Tennant, Mills, Diggle & Young, 2018).   
Empirical Paper Recruitment Appraisal 
 I encountered challenges during the recruitment process for the empirical paper.  One 
challenge related to accessing participants, as MND is a relatively rare condition, affecting 
only approximately 5,000 individuals in the UK (National Institute for Health and Care 
Excellence, 2015).  Worms (2001) estimated a prevalence rate for North America and Europe 
of around two per 100,000 of the population.  Therefore, it was difficult to recruit a large 
sample for this study although an a priori power calculation (using G*Power software based 
on 5-8 predictors, presuming a medium effect size of 0.15) suggested between 92 and 109 
participants were required (80% power, alpha = .05).  To reach this target, I recruited 
internationally to maximise my chances of gaining a sufficient sample.  I therefore used 
Qualtrics software to allow the survey to be conducted on an online platform, accessible to an 
international audience, however this assumed that participants would have internet access.  
Additionally, there are limitations to this method, such as biasing the recruitment towards a 
younger and more functionally able audience (Age UK, 2018; Topolovec-Vranic & 
Natarajan, 2016).  I recruited a fairly young sample which had a mean age below that of the 
average age of onset for MND.  Moreover, the majority of the sample I recruited had 
‘normal’ levels of depression, anxiety and stress and had mild to moderate levels of physical 
impairment.  Research suggests that younger people are more likely to participate in research 
which is advertised through social media and the internet (Topolovec-Vranic & Natarajan, 
2016).  Furthermore, Age UK (2018) recently reported that 36% of individuals aged 65 and 
older do not currently use the internet and that those with mobility difficulties have a 
decreased likelihood of using the internet.  Therefore, using an online survey and advertising 





my study online and via social media, could have contributed to the recruitment of a younger 
and more functionally able sample.  On balance I feel this was an appropriate method, as 
despite the limitations, I was able to reach participants that I may not have accessed through 
alternative methods.  However, future research may benefit from employing alternative 
recruitment strategies such as conducting face-to-face surveys at clinics, hospitals and care 
homes as well as utilising postal surveys in order to enhance the representation within the 
sample.    
Another challenge that I was presented with was gaining access to US participants.  I 
was able to access successfully participants from a range of countries, such as Australia, 
Canada, New Zealand and the UK through contact with organisations supporting individuals 
in these countries (see Appendix 3-A for list of organisations and how they shared the study 
information).  However, the main organisation supporting individuals with MND in the US 
would not share my study advert or details with their members, as the research was not being 
conducted by themselves, so they were unable to promote this.  This meant that I was not 
able to access a large pool of potential participants, which impacted the final sample size.  I 
tried alternative methods of recruiting from this country, by ‘tagging’ the individual chapters 
of this organisation into my study advert posts and I also contacted other, smaller 
organisations to see if they would be willing to share the details.  Only one of these other 
organisations offered to share my study details via different methods such as group meetings 
and through staff appointments.  However, despite this organisation expressing their 
willingness to share the information, only two of the participants recruited declared their 
nationality as ‘USA’.  Therefore, if I were to undertake this process again, I would consider 
establishing links with organisations in the US a priority from the outset of the process.  
Perhaps consulting them during the establishment of the research would have provided them 
with a role and incentive to collaborate with the recruitment process.   





 Interestingly, the country from which I recruited the greatest number of participants 
was New Zealand with a total of 21 participants reporting New Zealand or New Zealand 
European as their nationality.  
Another issue that I encountered during recruitment was the time taken to recruit 
participants.  I kept the survey online for as long as was practically possible and the overall 
duration for data collection was around 18 months.  This was a long duration considering the 
timescale for completion of a doctoral thesis and was only achieved as, during the data 
collection period, I had a period of maternity leave.  I would therefore advocate that 
researchers conducting research within this field take into consideration the amount of time 
required to recruit a sufficient sample size from this population.   
Conceptual Framework of Disability 
As this thesis sits within the clinical health psychology field, it felt important to 
consider the stance which I took with regards to concepts such as disability and the 
terminology used throughout.  I assumed a critical position towards the concept of disability 
and considered an alternative conceptual framework in which to view this to guide the write 
up of this thesis.  This was in an attempt to assume a socio-psychological position, as 
opposed to a diagnostic, pathologising approach which medical literature often adopts.  
Literature relating to MS and MND often refers to the ‘levels of disability’ (Amor, & van 
Noort, 2012; Andersen et al., 2012; Bromberg, 2015; Gulick, 1992; Kraft, Freal & Coryell, 
1986; Talbot & Marsden, 2008; Walsh & Walsh, 1989) that the condition brings.  However, 
this view can bring damaging assumptions with regards to an individual’s impairment and 
alternative views of the concept of ‘disability’ have been proposed to overcome the unhelpful 
narrative that can be associated with the term.  Simpson and Thomas (2014) argued that the 
concept of ‘structural and/or psycho-emotional disablism’ is a useful conceptual framework 





for understanding how society can impose limitations and barriers to an individual, making it 
appear that they lack these abilities.  The term ‘disablism’ was defined by Thomas (2007) as 
“a form of social oppression involving the social imposition of restrictions of activity on 
people with impairments and the socially engendered undermining of their psycho-emotional 
wellbeing” (p.73) and an individual’s ‘level of disability’ was viewed in the context of this 
concept throughout the literature review and empirical paper.  Therefore, the term ‘disability’ 
was replaced with the term impairment when considering physical limitations imposed by the 
condition, as I would argue that disability is a product of societal limitations as well as the 
physical limitations. 
 Another adjustment made to terminology was reflected in the empirical paper.  
‘Emotional lability’ is a diagnostic term that refers to involuntary changes in mood where 
strong feelings and emotions can occur, such as uncontrollable laughing or crying (Palmieri 
et al., 2009) and was used throughout the literature.  For the purpose of this thesis, this term 
was referred to as involuntary changes in mood as this is a more descriptive and meaningful 
way of expressing this experience for an individual.  This is also more in line with 
psychological concepts regarding emotional distress, fitting with a psychological formulation 
approach as opposed to a psychiatric diagnostic system (Johnstone & Dallos, 2014).     
Personal Reflections on the Research Process 
My reasons for embarking on this research project related to my own research 
interests in the area of neurodegenerative conditions, particularly MND.  My interest in MND 
stems from my own personal experiences of wanting to understand more about this condition 
and the psychological impacts of such a diagnosis, as my sister-in-law had personal 
experiences of this condition.  Her father was diagnosed with MND and she was his main 
carer until he passed away.  I have been privileged enough to gain an insight into some of the 
challenges that the condition presented to her father and their family members through her 





sharing her experiences.  I therefore wanted to explore this further and research some of the 
psychological impacts of this condition, as these aspects are often overlooked (McLeod, 
2007; Oh & Kim, 2017).  Through discussions with my sister-in-law regarding the 
psychological challenges that can be presented, stigma was discussed, as the perceptions and 
misconceptions of others often generated feelings of distress and could make practical tasks 
more difficult to manage.  The importance of family and friends was also discussed as a 
protective factor and through this, the concept of loss of social support as the condition 
progressed was identified.  The loss of social support can compound stigma, increasing 
psychological distress for the individual and their family, therefore I wanted to investigate 
whether this experience was shared by others experiencing this condition. 
After consulting the literature base, I identified a gap in this area as little or no 
research had been conducted assessing the influence of stigma and social support on 
psychological distress for people with MND.  Social support has been identified as a 
significant predictor of quality of life and depression in this population (Matuz, Birbaumer, 
Hautzinger & Kübler, 2010; Matuz, Birbaumer, Hautzinger & Kübler, 2015), but this used a 
very small sample size.  Furthermore, anxiety and stress had not been investigated.  Stigma 
has been identified as a significant predictor of quality of life for individuals with a 
neuromuscular condition (van der Beek, Bos, Middel and Wynia, 2013). However, 
individuals diagnosed with MND only made up 9% of the total number of participants in this 
study and distress had not been investigated.    
Having chosen a topic for my research paper, I then had to identify an appropriate and 
complementary systematic literature review.  I chose to focus on social support as more 
research had been conducted in this area, providing a larger set of studies to review.  I then 
chose to examine the relationship between social support and psychological variables, as this 
complemented the concept of psychological distress being investigated in the empirical 





paper.  However, there were insufficient studies investigating the relationship between social 
support and psychological variables in people with MND.  I therefore considered an 
alternative neurodegenerative condition which was more thoroughly researched than MND, 
MS.  Two previous reviews have been conducted in this area, which have focused on 
depression and MS (Arnett, Barwick & Beeney, 2008) and psychosocial correlates of 
adjustment in MS (Dennison et al., 2009).  There was some overlap between these and the 
current review, as perceived social support was included as a psychosocial factor within the 
Dennison et al. (2009) review and as a correlate of depression in the Arnett et al. (2007) 
review.  However, these reviews were conducted at least 10 years ago, and social support was 
not the focus of these reviews.  Furthermore, the way in which the Dennison et al. (2009) 
review was theorised differs from the current review, as they were seeking predictors of 
adjustment outcomes, whereas my review was seeking research investigating social support 
and its relationship with other psychological variables.  Therefore, the current review aimed 
expand on these, by identifying more recent research and by assessing the specific concept of 
perceived social support.   
Throughout the process of conducting this research, I gained a deeper appreciation of 
the challenges and difficulties experienced by individuals with a diagnosis of MND and their 
family members.  This impacted me personally in relation to my sister-in-law as, although I 
had previously recognised the impact this may have had, I had not appreciated the magnitude 
of this.  I have gained a greater respect for how she coped with these challenges and the 
resilience she has developed in order to manage these experiences.  This was compounded 
when I received emails from both individuals with a diagnosis of MND and by a family 
member who had recently lost her partner to the condition.  They shared their experiences 
with me of how distressing their journey had been from receiving the diagnosis, managing as 
the condition progressed, and ultimately the end of life stages.  Hearing these stories provided 





a profound contextual awareness to the statistical data that I had collected, by providing the 
human element that is often overlooked when conducting quantitative research.  
Future Research 
 Through the process of critically appraising this thesis, recommendations for future 
research were identified.  One recommendation relating to my personal reflections would be 
for more qualitative research to be conducted, exploring the stories of both individuals with 
MND and their family members/ carers.  Specifically, qualitative research investigating the 
experiences of felt and enacted stigma, and the role which social support plays in relation to 
this.  This type of research could enrichen the findings from this thesis by developing a 
contextual narrative in which the present results can be compared and viewed.  This could 
also inform future quantitative research, as through qualitatively exploring the relationships 
between stigma, social support and psychological distress, the mechanisms through which 
these relationships operate could be identified then tested through statistical methods. 
 During the systematic review process, I also identified that some qualitative research 
has been conducted on psychological variables such as coping (Dehghani, Neyeri & Ebadi, 
2017); adaptation (Dilorenzo, Becker-Feigeles, Halper & Picone, 2008), well-being (Hamed, 
Tariah & Hawamdeh, 2012) and the individuals experience of living with MS (Barton, 
Magilvy & Quinn, 1994).  However, no reviews have been conducted in the area of 
psychological variables, to the best of the author’s knowledge, and this topic may benefit 
from future research.   
 After consulting the literature base to identify potential reasons for differences 
between research participation uptake between different countries, I discovered a dearth of 
research in this area.  It would therefore be beneficial for research to be conducted which 
compares the attitudes towards participation in health research for different countries and 





cultures.  This could enhance the recruitment and participation process for future research, as 
this could identify countries in which attitudes towards participation is less favourable then 
work could be undertaken to establish the reasons behind this.  Moreover, more resources and 
methods of engagement could be applied to these countries/ cultures to enhance recruitment 
and establish more representative findings.   
 During the recruitment process and through my personal reflections it has become 
apparent that research into the impacts of stigma and a lack of social support in relation to 
psychological distress for the family members and carers of individuals with a diagnosis of 
MND is required.  I was contacted through twitter by a partner of an individual with MND 
asking if families and children could participate in this research as the impact that the 
condition had on their three children was of deep concern.  They added that the fallout of this 
condition was quite unique, and they were pleased to see interest shown in this most 
neglected aspect of MND.  Therefore, the psychological distress resulting from the impact of 
this condition is not only felt by the individual with MND, but their family members and 
carers too.  Hence, future research exploring this further is required to establish whether this 
experience is shared by other families and to what extent the psychological well-being of 
family members is impacted by stigma and lack of social support.  The results could be used 
to advocate for recognition of this impact by support services, so family members and carers 
can receive the support required to address these needs and interventions can be advised 
accordingly.  Additionally, stigma interventions aimed at a community/ structural levels as 
outlined in the empirical paper of this thesis would also benefit family members and carers 
alongside the individual with MND.   
Conclusions 





 I feel that I met the research aims and that the two papers complemented each other, 
as although they focused on two separate conditions, these both sit within the 
neurodegenerative discipline and the findings from each paper identified similar relationships 
between social support and variables representing psychological well-being/ distress.  There 
was coherence in terms of the predictor of interest (social support) and the inclusion of 
stigma in the empirical paper was also fitting with the concept of social factors and identity, 
which can include how individuals perceive themselves and the support they receive from 
others.   
Despite the issues encountered during the recruitment process of the empirical paper 
and the sample size being limited, this did not impact upon the identification of medium and 
large effect sizes in the results.  This suggests that a sufficient sample size was gained, and 
the overall process of recruitment was a success regardless of the challenges faced.   
The results of this thesis might be helpful in identifying clinical implications to raise 
awareness of the potential psychological consequences resulting from a lack of social support 
and experiencing felt stigma.  The findings might be beneficial to guide intervention planning 
to ensure that an individual’s psychological needs are recognised, addressed and appropriate 
interventions offered.  Recommendations for future research were also identified which could 
enhance the current literature base available and further explore these relationships to identify 
the mechanisms through which these relationships operate.  Moreover, qualitative research is 
advocated to explore the individual experiences of both individuals with MND and their 
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Appendix 3-A: List of Organisations 
Organisation Country Support Provided 
ALS Canada Canada Shared survey link on social 
media (Facebook and 
Twitter). 
ALS/MND Alliance International 
organisation 
Sent study details to 
worldwide associations 
asking them to share with 
their members.  Shared 
survey link on Twitter. 
ALS Society Quebec Canada Shared survey link on their 
social media and in their 
province.  Also shared with 
ALS Canada 
Lancaster Centre for Ageing 
Research 
UK Shared study details on social 
media. 
Les Turner Foundation USA Shared with their staff to 
cascade to members and 
through their support groups. 
Minds and Movement UK Shared study details on social 
media. 





MNDA UK Advertised study on the 
research page of their 
website and in their 
newsletter.   
MNDA Australia Australia Shared the study details on 
social media. 
MNDA New Zealand (NZ) New Zealand Shared with NZ MND 
Registry and shared on 
website and social media. 
MNDA Scotland Scotland Shared on Twitter and with 
MND clinical specialists to 
cascade. 
MNDA South Africa South Africa Shared study details with 
their members and in their 
newsletter. 
NZ MND Registry New Zealand Shared study details with all 
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Motor neurone disease (MND), also referred to as amyotrophic lateral sclerosis (ALS) and Lou 
Gehrig disease in the United States of America, is a fatal neurodegenerative disease (Pagnini, 
Philips, Bosma, Reece & Langer, 2015).  This condition affects the motor neurons in the brain and 
spinal cord and alters an individual’s ability to control voluntarily their muscle movements, leading 
to paralysis, swallowing difficulties, respiratory failure and ultimately, and only within a few years 
from diagnosis, death (Dib, 2003). 
Psychological distress is an important factor when considering individuals with a diagnosis of 
MND, not only in and of itself, but also because individuals with a higher level of well-being may 
have a lower risk of mortality than those experiencing distress, even when disease severity and 
length of illness is considered (McDonald, Wiedenfeld, Hillel, Carpenter & Walter, 1994).  
Therefore, an individual’s level of psychological distress can be viewed as a protective factor in 
terms of the impact of the diagnosis and exploring this further is also important given its 
contribution to overall quality of life.   
Due to the devastating nature of the condition, individuals with a diagnosis of MND are likely to 
experience psychological distress and decreased well-being (Pagnini et al., 2015).  Although a 
number of factors undoubtedly contribute to this, recent research has suggested that stigma may 
influence an individual’s sense of well-being in a negative manner in different populations living 
with physical health conditions including those experiencing lung, head and neck cancer (Lebel et 
al., 2011), individuals with epilepsy and migraines (Aydemir, Özkara, Ünsal & Canbeyli, 2011), 
individuals diagnosed with obesity (Carr & Friedman, 2005), individuals with Parkinson’s disease 
(Maffoni, Giardini, Pierobon, Ferrazzoli & Frazzitta, 2017) and individuals living with a diagnosis of 
HIV (Sanjuán, Molero, Fuster & Nouvilas, 2012).   
The term stigma was originally defined by Goffman (1963) as “an undesired differentness” and 
this has since been expanded to include two concepts of stigma; felt and enacted (Scambler & 
Hopkins, 1986).  ‘Felt stigma’ refers to a feeling of shame about being different and feeling that 
discrimination for this difference will occur, whereas, ‘enacted stigma’ refers to actual experience 
of this discrimination.     
The influence of stigma as a predictor of quality of life in individuals diagnosed with 
neuromuscular diseases, including MND, has been studied by Van Der Beek, Bos, Middel and 
Wynia (2013).  This study found that stigma was a major predictor of poorer quality of life, with 
‘felt stigma’ being a stronger predictor compared with ‘enacted stigma’.  However, this study was 
focused on quality of life, rather than psychological distress in particular, and individuals 
diagnosed with MND only made up 9% of the total number of participants.  Due to the fatality of 
MND in comparison to the other neuromuscular diseases included within the study (muscle 
disorder, junction disorder and peripheral nerve disorder), it seems important to study this 
population independently.   
 
Another important predictor to consider alongside stigma is social support.  Social support has 
been identified as an important factor in relation to stigma in a variety of conditions, including 
depression, where it has been reported that most research has found a negative association 
between the two factors (Mickelson, 2001).  Both social support and stigma have been identified 
as predictors of quality of life for individuals with epilepsy (Whatley, Dilorio & Yeager, 2010) and 
these factors have also been identified as predictors which contribute significantly to post-
traumatic growth for individuals with a diagnosis of HIV (Zeligman, Barden & Hagedorn, 2016).  It 





therefore feels important to also assess how the social aspects of a condition can affect 
psychological distress in individuals with MND. 
 
Rationale:  
This research aims to discover if there is a relationship between perceived stigma and 
psychological distress for people with a diagnosis of MND.  Also, discovering whether the strength 
of this relationship is stronger than that of other factors will be considered, such as demographics 
(age, gender, nationality and relationship status), clinical factors (time since symptom onset, time 
since diagnosis and symptom severity) and the psychological factor of social support.  It is 
believed that stigma will have a significant effect over and above other predictors of psychological 
distress.  If results support this, then this will highlight the importance of considering perceived 
stigma when assessing psychological distress in an individual diagnosed with MND.  This will 
provide evidence suggesting that providing interventions aimed at reducing perceptions of stigma 
would be beneficial and aims to address the causes of stigma and identify the levels of 
stigmatisation individuals with MND experience to promote awareness and challenge this socially.   
 
Research Question:  
The research question posed for this study is: Does perceived stigma influence psychological 
distress in individuals with motor neurone disease?   
 
Research Design:  
This will be a quantitative study using outcome measure scores for perceived stigma: Stigma Scale 
for Chronic Illnesses (SSCI; Rao et al., 2009) and levels of psychological distress: Depression, 
Anxiety and Stress Scale (DASS-21; Lovibond & Lovibond, 1995).  Demographic predictors will also 
be included in the analysis (age, gender, nationality and relationship status), along with clinical 
predictors including symptom severity (Self-Administered Amyotrophic Lateral Sclerosis 
Functional Rating Scale; SA-ALSFRS-R; Cedarbaum et al., 1999; Montes et al., 2006), time since 
symptom onset and time since diagnosis.  A psychological predictor will also be included which 
measures social support (Multidimensional Scale of Perceived Social Support; MSPSS; Zimet, 
Dahlem, & Farley, 1988).  The hypothesis will be analysed using a hierarchical block regression 
model to consider other potential predictors alongside the predictor of interest (stigma).   
 
Participants:  
Participants will include men and women aged 18 or over who have a self-reported diagnosis of 
MND or equivalent (e.g. ALS/ Lou Gehrig disease).  Inclusion criteria includes having English to a 
level to understand the questionnaires and having a diagnosis of MND or equivalent (e.g. ALS/ Lou 
Gehrig disease; confirmed through self-report). 
An a priori power calculation (using G*Power based on 5-8 predictors, presuming a medium effect 
size suggests approximately 100 participants will be required (80% power, alpha = .05).   
 
Materials: 
Stationery will be required for advertising materials (see Appendix A). 





A participant information sheet (see Appendix B), consent form (see Appendix C) and debrief 
sheet (see Appendix D) will be required. 
An electronic version of each of the questionnaires, including the self-report measures, will be 
required to input to the online survey (see Appendix E – K) 
Qualtrics software will be required to deliver the survey online. 
 
Recruitment: 
Participants will be recruited internationally by advertising the survey through various methods 
including through charities/ support services/ social media networks in the UK and internationally.  
This is due to the limited number of individuals with a diagnosis of MND in the UK alone which is 
estimated at 5,000 adults at any one time (Motor Neurone Disease Association; MNDA, 2017).   A 
Qualtrics survey will then be used to collect the data. 
Procedure: 
Questionnaires will be used to gain data via an online survey method, this will also include self-
report questions for demographic and clinical data.   
These questionnaires will assess levels of stigma (SSCI; Rao et al., 2009) and levels of psychological 
distress (DASS-21; Lovibond & Lovibond, 1995).  Measures will also be used to assess levels of 
social support (MSPSS; Zimet et al., 1988) and symptom severity (Self-Administered Amyotrophic 
Lateral Sclerosis Functional Rating Scale; SA-ALSFRS-R; Cedarbaum et al., 1999; Montes et al., 
2006).  Data will also be collected via self-report method for demographic variables such as age, 
gender, nationality and relationship status and clinical variables such as time since symptom onset 
and time since diagnosis. 
Once the survey has begun then the information provided will be anonymous meaning that no 
personal identifiable information will be held.   The study findings will be produced into a report 
which may be published, however no personal identifiable information will be included in the 
report.  If a participant wishes to access a copy of the results of the study then their personal 
details will be held long enough to send out this information, then it will be destroyed and this 
information will be kept confidential throughout the process.  The data collected for this study will 
be stored securely and only the researchers conducting this study will have access to these data: 
o The files on the computer will be encrypted (that is no-one other than the researchers will 
be able to access them) and the computer itself password protected. 
o Lancaster University will keep the anonymised data for a period of 10 years after the 
study has finished. 
 
Data Analysis: 
The method of analysis which is to be used is a hierarchical block regression model.  Predictors 
will be entered in four blocks: Demographics (age, gender, nationality and relationship status), 
clinical variables (symptom severity, time since symptom onset and time since diagnosis), the 
psychological variable (social support) and stigma.  These blocks will predict the outcome variable 
of psychological distress (depression, anxiety and stress).  This will be completed using SPSS 
software.  This is to understand if scores of stigma predict scores on measures of psychological 
distress as it is hypothesised that stigma will have a significant effect over and above other 
predictors of psychological distress.  The inclusion of other predictors allows for comparison 
between these and stigma to identify which is the strongest predictor for psychological distress in 
this population.   
 






A potential issue is regarding recruitment as there is a low prevalence rate of MND in the UK 
alone.  To address this the survey will be completed online allowing international access to the 
survey and advertising will be targeted internationally to expand the recruitment pool.  This will 
be aimed at English speaking countries and at individuals who speak English that live in other 
countries, however, the eligibility criteria for the study requires the ability to speak English 
proficiently in order to understand the questionnaires.  Advertising will be aimed at support 
services and through social media to access as many participants as possible.  
 
Moreover, due to the nature of MND, the physical functioning of participants may be reduced 
meaning that depending upon the participant’s stage of the disease, their ability to enrol 
themselves in the study or manually complete the online surveys may be an issue.  If this is the 
case and the participant does not have the physical capability or assistive technology to complete 
the survey, but does wish to take part then it may be possible to have a carer complete this 
alongside the participant based upon the participant’s communicated responses. 
 
Dissemination: 
Following completion, the study findings will be submitted as my DClinPsy thesis and will be 
presented to peers and staff at Lancaster University.  This presentation will be available on the 
University’s website for the public to access.  There could be the opportunity to publish the 
findings in the Motor Neurone Disease Association newsletter and on their website, along with 
any other support services that have been approached.  The findings will also be put forward for 
publication in a peer reviewed journal and/ or presented at conferences. 
Ethical issues: 
Confidentiality of participants will be maintained as once the survey has begun then the 
information provided will be anonymised meaning that no personal identifiable information will 
be held. 
Participants will be provided with an information sheet outlining the proposed research and 
informed consent will be gained before the survey commences.  Participants will be unable to 
withdraw their data once the survey has begun as all data is not identifiable at this stage, this is 
outlined in the consent form (see Appendix C). 
The only risk of harm identified is around highlighting to participants the limitations that they are 
experiencing because of their diagnosis.  This includes highlighting potential perceived stigma that 
they may be experiencing.  Thus, advice and further sources of support will be provided at the end 
of the survey as part of the debrief procedure to ensure that participants are able to access 
support for any difficulties they are currently experiencing.   
In terms of gaining valid consent, all participants will be aged 18 or over and will be provided with 
an information sheet which they will have the option of downloading and can ask questions by 
contacting the researcher prior to completing the survey and providing their consent.  They will be 
unable to withdraw their data once the survey has begun as all data is not identifiable at this 
stage; this is outlined in the consent form (see Appendix C).  
In terms of advice giving and debriefing, participants will be shown a debrief sheet following 
completion of the survey with the option of downloading this, which includes contact details of 
the researcher.  They will have the opportunity to ask questions or raise concerns directly with the 
researcher or through the complaints procedure outlined.  Further sources of support and advice 
will also be provided at this stage in case they require further support. 
 






July – September 2017 – Submit and gain ethical approval; keep reflective diary of process; keep 
notes and copies of all documents relevant to process. 
October – December 2017 – Conduct data collection for main study; write draft introduction and 
method sections; keep notes of data collection; keep reflective diary. 
January – February 2018 – Analyse data; hand in draft introduction and method by end of 
January; write draft abstract, results and discussion. 
November 2018 – December 2018 - Hand in complete first draft of research paper by end of 
November; keep checking for new, relevant references; complete reflective diary; produce 
appendices; write draft thesis abstract. 
January 2019 – February 2019 – Complete final version of research paper; collate and finalise 
appendices; finalise thesis abstract; complete cover sheet; hand in complete draft thesis to 
Programme by end of March; soft-bind and hand in final thesis by deadline. 
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Appendix 4-A: Study Advert 
 
Does perceived stigma influence psychological distress in individuals with 
motor neurone disease/ amyotrophic lateral sclerosis/ Lou Gehrig disease? 
 
My name is Natalie Leigh and I am conducting this research as a student in the Doctorate of 
Clinical Psychology programme at Lancaster University, Lancaster, United Kingdom. 
 
What is the study about? 
This study aims to find out if there is a relationship between levels of stigma and levels of 
psychological distress experienced by individuals with a diagnosis of motor neurone disease 
(MND) also known as amyotrophic lateral sclerosis (ALS) and Lou Gehrig disease.  In this 
study, the term stigma means a feeling of shame about being different and feeling that you 
will be treated differently because of this, or actually being treated differently because of 
this difference.  The study also aims to find out the strength of this relationship compared to 
other important factors such as symptom severity and social support. 
 
Who can participate in this study? 
Anyone aged 18 or over, who has a diagnosis of MND/ ALS/ Lou Gehrig disease and can 
complete an online survey regarding their experiences of stigma and well-being is eligible to 
take part in this study.   
 
What will I be asked to do if I take part? 
If you decide you would like to take part, you would be asked to complete an online survey 
to assess levels of stigma, well-being, self-esteem, social support and symptom severity.  It 
should take you about 15 to 20 minutes to complete and need not be completed at one 
sitting.  Someone can help you complete it if you would like them to.   
 
Interested in taking part in this research? 
If you would like to take part in this research, please click the following link to access 
the online survey: XXXXXXXXXXX 
 
Or alternatively for further information contact the main researcher: Natalie Leigh 
on n.leigh@lancaster.ac.uk or phone 07508 375657. 







  Appendix 4-B: Participant Information Sheet 
Participant Information Sheet 
 
Does perceived stigma influence psychological distress in individuals with motor 
neurone disease? 
My name is Natalie Leigh and I am conducting this research as a student in the Doctorate of 
Clinical Psychology programme at Lancaster University, Lancaster, United Kingdom. 
 
What is the study about? 
This study aims to find out if there is a relationship between levels of stigma and levels of 
psychological distress experienced by individuals with a diagnosis of motor neurone disease 
(MND) also known as amyotrophic lateral sclerosis (ALS) and Lou Gehrig disease.  The study 
also aims to find out the strength of this relationship compared to other important factors 
such as symptom severity and social support. 
 
Why have I been approached? 
You have been approached because the study requires information from people who have 
MND/ ALS/ Lou Gehrig disease. 
 
Do I have to take part? 
No.  It’s completely up to you to decide if you take part, taking part in this research is 
completely voluntary.  You will have the opportunity to ask questions and raise concerns at 
any time.  If you agree to take part in the research, once the online survey has started then 
the information provided will be anonymised meaning that no personal identifiable 
information will be held.  Due to this, you will not be able to withdraw your data once you 
have begun the survey as it will not be possible to identify your responses.   
 
What will I be asked to do if I take part? 
If you decide you would like to take part, you would be asked to complete an online survey 
involving questionnaires which will measure levels of stigma, levels of psychological distress, 
social support and symptom severity.  The online survey will also request some information 
such as your age, gender and the time since you received your diagnosis.  If you agree to 
take part in the research, once the online survey has started then the information provided 
will be anonymised meaning that no personal identifiable information will be held.  Due to 
this, you will not be able to withdraw your data once you have begun the survey as it will 
not be possible to identify your responses.   
 
Will my data be identifiable? 
Once the survey has begun then the information provided will be anonymous meaning that 
no personal identifiable information will be held.   The study findings will be produced into a 
report which may be published, however no personal identifiable information will be 





included in the report.  If a participant wants to access a copy of the results of the study 
then their personal details will be held long enough to send out this information, then it will 
be destroyed and this information will be kept confidential throughout the process.  The 
data collected for this study will be stored securely and only the researchers conducting this 
study will have access to this data: 
o The files on the computer will be encrypted (that is no-one other than the 
researchers will be able to access them) and the computer itself password protected. 
o Lancaster University will keep your anonymised data for a period of 10 years after 
the study has finished. 
 
What will happen to the results? 
The results will be summarised and reported in a thesis and may be submitted for 
publication in an academic or professional journal and/ or presented at conferences.  A 
presentation will be available on the Lancaster University website for the public to access.  
There could be the opportunity to publish the findings in the Motor Neurone Disease 
Association newsletter (in the UK) and on their website, along with any other support 
services that have been approached during the advertisement of this study. 
 
Are there any risks? 
There are no risks anticipated with participating in this study.  However, if you experience 
any distress following participation you are encouraged to contact the resources provided at 
the end of this sheet. 
 
Are there any benefits to taking part? 
Although you may find participating interesting, there are no direct benefits in taking part. 
 
Who has reviewed the project? 
This study has been reviewed and approved by the Faculty of Health and Medicine Research 
Ethics Committee at Lancaster University. 
 
Where can I obtain further information about the study if I need it? 
If you have any questions about the study, please contact the main researcher: 
 
Natalie Leigh 






Tel: +44 (0)7508 375657 
 
Or, Research Supervisor: 
Dr Fiona Eccles,  
Lecturer 
Division of Health Research 










Tel: +44 (0)1524 592807 
 
Complaints  
If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researcher, you can contact:  
 
Professor William Sellwood  
Tel: +44 (0)1524 593998 
Email: b.sellwood@lancaster.ac.uk 
Division of Health Research 
Lancaster University  
Lancaster, UK  
LA1 4YG 
 
If you wish to speak to someone outside of the Doctorate in Clinical Psychology Programme, 
you may also contact:  
 
Professor Roger Pickup  
Associate Dean for Research  
Tel: +44 (0)1524 593746  
Email: r.pickup@lancaster.ac.uk  
Faculty of Health and Medicine (Division of Biomedical and Life Sciences)  
Lancaster University  
Lancaster, UK  
LA1 4YG 
 
Thank you for taking the time to read this information sheet. 
 
Resources in the event of distress 
Should you feel distressed either as a result of taking part, or in the future, the following 
resources may be of assistance.  
 
1. For UK residents: 
Motor Neurone Disease Association 
David Niven House 




Tel: (+44) 01604 250505 
Email: enquiries@mndassociation.org 
Website: www.mndassociation.org 






Your local G.P. surgery can also provide advice and direct you to local services to support 
you in times of distress. 
 
2. For international participants: 
Australia – MND Australia  
Suite 260, Level 26 
100 Miller Street 








Canada – ALS Canada 






Tel: (+1) 416 497 2267 
Website: https://www.als.ca/ 
 
New Zealand – MND New Zealand 
MND Association National Office 









USA - ALS Association 
1275 K Street NW,  
Suite 250 
Washington DC  
20005 
USA 











Appendix 4-C: Consent Form 
Consent Form 
 
Study Title: Does perceived stigma influence psychological distress in individuals 
with motor neurone disease? 
 
We are asking if you would like to take part in a research project which aims to investigate 
whether level of perceived stigma influences psychological distress for individuals with 
motor neurone disease (MND, also known as amyotrophic lateral sclerosis; ALS/ Lou Gehrig 
disease).   
Before you consent to participating in the study we ask that you read the participant 
information sheet and then, if you agree to continue, click each statement below to say you 
agree.  If you have any questions or queries before signing the consent form please contact 
the principal investigator, Natalie Leigh on the details given on the participant information 
sheet. 
 
Before proceeding to the survey, I confirm that: 
 
• I have read the participant information sheet and understand what is expected of 
me within this study. 
• I confirm that I understand that any responses/information I give will remain 
anonymous. 
• I confirm that I understand that once I begin this survey that my responses will be 
anonymous and therefore cannot be withdrawn from the study. 
• My participation is voluntary. 
• I consent for the information I provide to be discussed with the researcher’s 
supervisor at Lancaster University. 
• I consent to Lancaster University keeping the anonymised data for a period of 10 
years after the study has finished. 















Appendix 4-D: Debrief Sheet 
Debrief Sheet: 
Does perceived stigma influence psychological distress in individuals with motor 
neurone disease? 
Thank you very much your participation in this research; your time and effort has been 
greatly appreciated.   
 
This research aimed to discover if there is a relationship between perceived stigma and 
psychological distress for people with motor neurone disease (MND) also known as 
amyotrophic lateral sclerosis (ALS) and Lou Gehrig disease.  This also aimed to discover the 
strength of this relationship compared to other factors such as symptom severity and social 
support.  It is believed that stigma will have a significant effect over and above other 
predictors of well-being.  If results support the belief that stigma has a significant effect over 
and above that of other predictors of psychological distress, then this will highlight the 
importance of considering perceived stigma when assessing psychological distress in an 
individual diagnosed with MND.  This will provide evidence suggesting that providing 
interventions aimed at reducing perceptions of stigma would be beneficial including 
challenging perceptions in society.   
 
If you would like to receive the results of this study or if you have any questions then please 











Tel: +44 (0)7508 375657 
 
Thank you for taking the time to read this debrief sheet. 
 
Resources in the event of distress 
Should you feel distressed either as a result of taking part, or in the future, the following 
resources may be of assistance.  
 
1. For UK residents: 





Motor Neurone Disease Association 
David Niven House 








Your local G.P. surgery can also provide advice and direct you to local services to support 
you in times of distress. 
 
2. For international participants: 
Australia – MND Australia  
Suite 260, Level 26 
100 Miller Street 








Canada – ALS Canada 






Tel: (+1) 416 497 2267 
Website: https://www.als.ca/ 
 
New Zealand – MND New Zealand 
MND Association National Office 









USA - ALS Association 





1275 K Street NW,  
Suite 250 
Washington DC  
20005 
USA 




To download a copy of this Debrief Sheet please click on the link below: 






























Appendix 4-E: Self-Report Questionnaire 
Self-Report Questionnaire 
1. What is your age?   
 
3. What is your gender?   
 
 
2. What is your nationality? 
 




6. How long has it been since you were diagnosed with motor neurone disease (MND/ ALS/ Lou Gehrig 
disease)?   
 
4. What is your relationship status?   
a. Single 
b. Cohabiting 
c. Married/ civil partnership 
d. Divorced 
e. Widowed 
f. Other  
 
 
7. Have you got carer assistance in completing this survey? 
 
 





Appendix 4-F: Stigma Scale for Chronic Illness (SSCI) 
 
Please answer this on a scale of:  Never, Rarely, Sometimes, Often or Always. 





 Never (1) Rarely (2) 
Sometimes 
(3) 
Often (4) Always (5) 
Because of 






o  o  o  o  o  
Because of 
my illness, I 
felt left out of 
things (2)  
o  o  o  o  o  
Because of 




situations (3)  
o  o  o  o  o  
Because of 






o  o  o  o  o  
I was 
unhappy 





o  o  o  o  o  
Because of 
my illness, it 
was hard for 
me to stay 
neat and 
clean (6)  
o  o  o  o  o  






my illness, I 
worried that I 
was a burden 
to others (7)  




illness (8)  





limitations (9)  




speech (10)  
o  o  o  o  o  
Because of 




o  o  o  o  o  
I tended to 
blame myself 
for my 
problems (12)  














with me (14)  
o  o  o  o  o  














unkind to me 
(16)  




fun of me (17)  





looking at me 
(18)  





stare at me 
(19)  
o  o  o  o  o  
Because of 
my illness, I 
was treated 
unfairly by 
others (20)  




to ignore my 
good points 
(21)  
o  o  o  o  o  







though it was 
my fault I 
have this 
illness (22)  
o  o  o  o  o  
People with 





about it (23)  
o  o  o  o  o  
I lost friends 
by telling 
them that I 
have this 
illness (24)  























Appendix 4-G: Depression, Anxiety and Stress Scale (DASS-21) 
Please read each statement and please select an answer which indicates how much the statement 
applied to you over the past week.  There are no right or wrong answers.  Do not spend too much 
time on any statement.   
The rating scale is as follows:  
Did not apply to me at all – NEVER 
Applied to me to some degree, or some of the time - SOMETIMES 
Applied to me a considerable degree, or a good part of the time – OFTEN 
Applied to me very much, or most of the time - ALMOST ALWAYS 





 Never (1) Sometimes (2) Often (3) 
Almost Always 
(4) 
I found it hard to 
wind down (1)  o  o  o  o  
I was aware of 
dryness of my 
mouth (2)  
o  o  o  o  
I couldn't seem 
to experience 
any positive 
feeling at all (3)  







in the absence 
of physical 
exertion) (4)  
o  o  o  o  
I found it difficult 
to work up the 
initiative to do 
things (5)  
o  o  o  o  
I tended to over-
react to 
situations (6)  
o  o  o  o  
I experienced 
trembling (e.g. in 
the hands) (7)  
o  o  o  o  
I felt that I was 
using a lot of 
nervous energy 
(8)  
o  o  o  o  





I was worried 
about situations 
in which I might 
panic and make 
a fool of myself 
(9)  
o  o  o  o  
I felt that I had 
nothing to look 
forward to (10)  
o  o  o  o  
I found myself 
getting agitated 
(11)  
o  o  o  o  
I found it difficult 
to relax (12)  o  o  o  o  
I felt down-
hearted and blue 
(13)  
o  o  o  o  
I was intolerant 
of anything that 
kept me from 
getting on with 
what I was doing 
(14)  
o  o  o  o  
I felt I was close 
to panic (15)  o  o  o  o  





o  o  o  o  
I felt I wasn't 
worth much as a 
person (17)  
o  o  o  o  
I felt that I was 
rather touchy 
(18)  
o  o  o  o  





I was aware of 
the action of my 
heart in the 
absence of 
physical exertion 
(e.g. sense of 
heart rate 
increase, heart 
missing a beat) 
(19)  
o  o  o  o  




o  o  o  o  
I felt that life was 
meaningless 
(21)  























Appendix 4-H: Multidimensional Scale of Perceived Social Support (MSPSS) 
We are interested in how you feel about the following statements.  Please read each statement 
carefully.  Indicate how you feel about each statement using the scale below.   
 
1 = Very Strongly Disagree 
2 = Strongly Disagree 
3 = Mildly Disagree 
4 - Neutral 
5 = Mildly Agree 
6 = Strongly Agree 
7 = Very Strongly Agree 





 1 (1) 2 (2) 3 (3) 4 (4) 5 (5) 6 (6) 7 (7) 







need. (1)  
o  o  o  o  o  o  o  
















o  o  o  o  o  o  o  






family. (4)  
o  o  o  o  o  o  o  
I have a 
special 
person 




me. (5)  
o  o  o  o  o  o  o  









me. (6)  









o  o  o  o  o  o  o  




family. (8)  










o  o  o  o  o  o  o  
















o  o  o  o  o  o  o  









































Appendix 4-I: Self-Administered Amyotrophic Lateral Sclerosis Functional Rating 
Scale (SA-ALSFRS) 
Amyotrophic lateral sclerosis (ALS) is also known as motor neurone disease (MND) and Lou 
Gehrig disease. 
The following questions refer to how you are currently functioning at home.  Please read 
each item carefully and base your answers on your functioning today compared to the time 
before you had any symptoms of ALS/ MND/ Lou Gehrig disease.  Please select the response 
that best fits your functional status today.  
Q1)  
Compared to the time before you had symptoms of ALS/ MND/ Lou Gehrig disease: 
 
Have you noticed any changes in your speech? 
o No change  (1)  
o Noticeable speech difference  (2)  
o Speech has changed; asked often to repeat words or phrases  (3)  
o Speech has changed; sometimes need the use of alternative communication methods (i.e. 
computer, writing pad, letter board or eye chart)  (4)  









Q2) Have you noticed any changes (increases) in the amount of saliva in your mouth (regardless of 
any medication use)? 
o No change  (1)  
o Slight but definite excess of saliva with or without night time drooling  (2)  
o Moderate amounts of excessive saliva with or without minimal day time drooling  (3)  
o Marked amounts of excessive saliva with some daytime drooling  (4)  




Q3) Compared to the time before you had symptoms of ALS/ MND/ Lou Gehrig disease: 
 
 
Have there been any changes in your ability to swallow? 
o No changes (all foods and liquids)  (1)  
o Some changes in swallowing or occasional choking episodes (including coughing during 
swallowing)  (2)  
o Unable to eat all consistencies of food and have modified the consistency of foods eaten  (3)  
o Use a feeding tube (PEG) to supplement what is eaten by mouth  (4)  









Q4) Has your handwriting changed? Please choose the best answer that describes your handwriting 
with your dominant (usual) hand without a cuff or brace. 
o No changes  (1)  
o Slower and/or sloppier but all the words are legible  (2)  
o Not all words are legible  (3)  
o Able to hold a pen but unable to write  (4)  




Q5) The following question refers to your ability to cut foods and handle utensils (feed yourself) 
compared to before you had symptoms of ALS/ MND/ Lou Gehrig disease.  If most of your nutrition 
is through a feeding tube (PEG), skip to part b of this question.  If you eat most of your meals by 




Q5a) Compared to the time before you had symptoms of ALS/ MND/ Lou Gehrig disease: 
 
 
Cutting food and handling utensils: 
o No change  (1)  
o Somewhat slow and clumsy (or different than before) but no assistance or adaptive equipment  
(2)  
o Sometimes need help with cutting more difficult foods  (3)  
o Food must be cut by someone else but can feed slowly without assistance  (4)  
o Need to be fed  (5)  
 







Q5b) Using a feeding tube (PEG) 
o Use PEG without assistance or difficulty  (1)  
o Use PEG without assistance however may be slow and/or clumsy  (2)  
o Require assistance with closures and fasteners  (3)  
o Provide minimal assistance to caregiver  (4)  




Q6) Compared to the time before you had symptoms of ALS/ MND/ Lou Gehrig disease: 
 
 
Has your ability to dress and perform self-care activities (i.e. bathing, teeth brushing, shaving, 
combing your hair, other hygienic activities) changed?  
o No change  (1)  
o Perform self-care activities without assistance but with increased effort or decreased efficiency  
(2)  
o Require intermittent assistance or use different methods (i.e. sit down to get dressed, fasten 
buttons with a fastener or your non-dominant hand)  (3)  
o Require daily assistance  (4)  









Q7) Has your ability to turn in bed and adjust the bed clothes (i.e. cover yourself with the sheet or 
blanket) changed? 
o No change  (1)  
o Can turn in bed and adjust the bed clothes without assistance but it is slower or more clumsy  (2)  
o Can turn in bed OR adjust the bed clothes without assistance but with great difficulty  (3)  
o Can initiate turning in bed or adjusting the bed clothes but require assistance to complete the 
task  (4)  




Q8) Compared to the time before you had symptoms of ALS/ MND/ Lou Gehrig disease: 
 
 
Has your ability to walk changed? 
o No change  (1)  
o Walking has changed but do not require any assistance or devices (i.e. foot brace, cane, walker)  
(2)  
o Require assistance to walk (i.e. cane, walker, foot brace or hand held assistance)  (3)  
o Can move legs or stand up but unable to walk from room to room  (4)  









Q9) Has your ability to climb stairs changed? 
o No change  (1)  
o Slower  (2)  
o Unsteady and/or more fatigued  (3)  
o Require assistance (i.e. using the handrail, cane or person)  (4)  




Q10) Compared to the time before you had symptoms of ALS/ MND/ Lou Gehrig disease: 
 
 
Do you experience shortness of breath or have difficulty breathing? 
o No change  (1)  
o Shortness of breath only with walking  (2)  
o Shortness of breath with minimal exertion (i.e. talking, eating, bathing or dressing)  (3)  
o Shortness of breath at rest while either sitting or lying down  (4)  









Q11) Do you experience shortness of breath or have difficulty while lying down on your back? 
o No change  (1)  
o Occasional shortness of breath while lying on back but don't routinely use more than two (2) 
pillows to sleep  (2)  
o Shortness of breath while lying on back and require more than two pillows (or an equivalent) to 
sleep  (3)  
o Can only sleep sitting up due to shortness of breath  (4)  
o Require the use of respiratory (breathing) support (BiPAP® or invasive ventilation via 




Q12) Compared to the time before you had symptoms of ALS/ MND/ Lou Gehrig disease: 
 
 
Do you require respiratory (breathing) support? 
o No respiratory support  (1)  
o Intermittent use of BiPAP®  (2)  
o Continuous use of BiPAP® at night  (3)  
o Continuous use of BiPAP® at night and during the day (nearly 24 hours per day)  (4)  









Q13) Please indicate who completed this survey: 
o Patient  (1)  
o Patient with assistance  (2)  
o Patient with assistance from caregiver or family member  (3)  




 (BiPAP® is commonly used to describe non-invasive positive pressure ventilation and its use here in 











































Appendix 4-K: Ethics Amendment 
An amendment was sought regarding the wording of the participant information sheet, 
consent form and debrief form to enhance the flow of the online survey.  This also included 
the option for the participant information sheet and debrief sheet to be downloaded along 
with a change in the timescale of the project.  This amendment was granted approval to be 




















Appendix 4-L: FHMREC Amendment Approval Letter 
